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Abstract
Implantable Wireless               
Intraocular Pressure Sensors 
Thesis by 
Po-Jui Chen 
Doctor of Philosophy in Electrical Engineering 
California Institute of Technology 
The work in this thesis aims to develop a suite of biomedical microdevice 
implants, with an intense focus on pressure sensors, for glaucoma study and management 
featuring the enabling micro-electro-mechanical-system (MEMS) technologies and the 
use of parylene (poly-para-xylene) as a biocompatible MEMS material.  The problems 
of the debilitating eye disease glaucoma threaten tens of millions of people worldwide 
with loss of vision, and are not completely resolved using the current non-optimal clinical 
procedures.  Given the relation of neuropathy and the physiological parameter of 
intraocular pressure (IOP) in glaucoma from clinical findings, such parylene-based 
MEMS implants are investigated to realize physical IOP monitoring and regulation, and 
further to accomplish continuous, direct, accurate, reliable, and more effective glaucoma 
detection and treatment. 
xMiniaturized parylene-based passive pressure sensors are presented in this thesis 
for IOP monitoring.  Complete design, fabrication, characterization, and analysis of such 
MEMS implants are described to demonstrate their feasibility, covering both engineering 
and surgical/biological aspects of the proposed applications.  Their passive behaviors, 
based on the comprised micromechanical structures, facilitate unpowered device 
operations.  In addition, such devices are microfabricated in suitable form factors so that 
minimally invasive suture-less implantation procedures are possible, minimizing time and 
complexity of the surgeries.  Two types of micromachined wireless pressure sensors are 
developed utilizing optical and electrical sensing methodologies, respectively, to explore 
the possibility of the proposed implant approach.  On-bench experimental results verify 
that wireless pressure sensing with 1 mmHg accuracy in the 0–100 mmHg range can be 
achieved using both types of devices.  Surgical studies, including ex vivo and in vivo
animal tests, confirm the bioefficacy and biostability of the device implants in the 
intraocular environment.  With the attempt of providing implementation concepts of the 
MEMS implant approaches for ultimate glaucoma study and management in practice, 
system-level designs and configurations involving such microdevice implants are briefly 
described as well.  Micromachined passive-valved flow-control devices with designed 
surgical and engineering features are also developed (experimentally achieving 0–100 
mmHg and 0–10 ?L/min pressure and flow rate regulation ranges) to investigate the 
feasibility and possibility of such implant approach for unpowered physical IOP 
regulation in glaucoma treatment. 
xi
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CHAPTER 1
GLAUCOMA AND INTRAOCULAR 
PRESSURE
1.1 Clinical Problems of Glaucoma 
Glaucoma is a debilitating eye disease that chronically damages the optic nerve 
and results in loss of vision and blindness for tens of millions of people worldwide [1–5].  
It is the second leading cause of blindness in the world, according to the World Health 
Organization (WHO), after cataracts.  Estimated incidences of glaucoma will occur to 
over 60 million people worldwide by 2010.  Although blindness ranked third (after 
cancer and heart disease) as people’s major fear, very few people are aware of glaucoma 
in its early development because there are no perceivable symptoms, making it extremely 
difficult to diagnose before it is already quite advanced and induces permanent visual 
damage.  In fact, unfortunately, 10%–25% of people with glaucoma who receive clinical 
 2  
treatments still experience loss of vision and blindness.  The loss of vision from 
glaucoma starts with patients missing objects to the side and out of the corner of their eye.  
Gradually patients lose their peripheral (side) vision and seem to be looking through a 
tunnel, as shown in Figure 1-1.  Over time, even their straight-ahead vision may decrease 
until no vision remains. 
(a)                         (b) 
Figure 1-1: Loss of vision by glaucoma. (a) Normal vision. (b) Same scene as viewed by 
a patient with glaucoma. Images courtesy of National Eye Institute. 
Pathological studies indicate that loss of vision in glaucomatous eyes results from 
damaged optic nerves in a characteristic pattern of optic neuropathy of the eye.  The optic 
nerve is a bundle of more than 1 million nerve fibers located at the posterior segment of 
the eye, as shown in Figure 1-2.  It provides a connecting neural pathway to transfer 
visual information from the retina to the brain.  Ophthalmoscopic examination of a 
glaucomatous eye, as shown in Figure 1-3, reveals the cupping of the optic disc as an 
indication of optic nerve damage progression, which leads to loss of vision. 
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Figure 1-2: Anatomy of the human eye. Drawing courtesy of NIH Medical Arts. 
Figure 1-3: Ophthalmoscopic examination of glaucomatous eye with optic disc cupping 
indication. The arrows indicate the edge of the “cup” of the optic disc. The pale region of 
the cup is interpreted where optic nerve damage occurs. Image adapted from [6].  
 4  
1.2 Physiological Influence of Intraocular Pressure on Glaucoma 
Although the mechanism of optic nerve damage by glaucoma is not resolved yet, 
the mostly accepted hypothesis is the adverse suppression from abnormally elevated 
intraocular pressure (IOP) induced by glaucoma, as shown in Figure 1-4.  The elevated 
IOP hypothetically obstructs the blood flow to the optic nerve, leading to damage and 
ultimate loss of the nerve (i.e., optic disc cupping, as shown in Figure 1-3).  Note that the 
damage is not accompanied by any pain even while permanent and irreversible, meaning 
the damaged optic nerve can not be cured or regained.  Current clinical treatments 
including medications and/or surgeries can only prevent the damage progression from 
further visual deterioration.  Therefore, lifelong monitoring and immediate treatment are 
definitely necessary for successful glaucoma management. 
Figure 1-4: Illustration of optic nerve damage mechanism. Drawing courtesy of A.D.A.M. 
Abnormal elevation of IOP results from accumulation of ocular fluid in 
glaucomatous eyes.  In normal eyes, a clear fluid called aqueous humor flows 
continuously within the eye chamber and nourishes nearby tissues. The aqueous humor is 
produced primarily from the ciliary processes [7] and drained from the anterior chamber 
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at an open angle where the cornea and iris meet, as shown in Figure 1-5.  When the fluid 
reaches the angle, it flows through a spongy meshwork called trabecular meshwork, 
analogous to a drain, and leaves the eye.  The production rate of aqueous humor 
corresponds to a turnover rate of approximately 1% of the anterior chamber volume per 
minute (2–3 ?L/min) [7, 8]; in a balance with the drainage rate this provides good 
circulation to maintain sufficient ocular rigidity and visual acuity.  The production varies 
diurnally but is relatively independent of IOP.  More details of aqueous humor production 
and drainage mechanisms can be found in [7].  In glaucomatous eyes, although the 
aqueous humor production is unaffected, its drainage is impeded at the angle through the 
influenced meshwork drain, leading to fluid accumulation, IOP elevation, and ultimately 
optic nerve damage.  Specifically, this form of glaucoma is called open-angle glaucoma 
[3] and is the most common and the most referenced type.  Other forms such as low-
tension (normal-tension, where no abnormal IOP elevation occurs), angle-closure, 
congenital, and secondary glaucomas also exist with different causes and medical 
complications, but they are not as common as the open-angle form.  Consequently, only 
diagnoses and treatments for open-angle glaucoma are described in this work.  In spite of 
no set threshold for an IOP that causes glaucoma, it is generally recognized that normal 
IOP ranges from 10–15 mmHg, and values over 15–20 mmHg are considered at risk.  
Because elevated IOP is highly associated with glaucoma, this crucial risk factor needs to 
be carefully monitored and controlled, even in a real-time (in situ) fashion.  Current 
clinical procedures for IOP monitoring and regulation are described in the following 
sections, and concepts of the correspondingly proposed MEMS-implant-based 
approaches in this work are presented in Chapter 2. 
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Figure 1-5: Circulation path of aqueous humor in the human eye. Drawing courtesy of 
National Eye Institute. 
1.3 Clinical Procedures for Intraocular Pressure Monitoring 
 Current clinical procedures for IOP measurement utilize applanation tonometry [9] 
as the standard method.  The concept, as shown in Figure 1-6, is to apply a measurable 
force to the corneal surface with a probe.  An ophthalmologist examines when a portion 
of the cornea is flattened out with the advance of the probe and measures how much 
applanation force is applied.  As a result, this force balancing the internal pressure of the 
cornea over a determined area can be obtained to calculate the related IOP.  Goldmann 
applanation tonometry (GAT) [10] and tono-pen (Reichert Inc., Depew, NY) are the 
representative examples of this method.  Compared with this contact tonometry, the non-
contact tonometry [11, 12], such as pneumotonometry (i.e., air-puff tonometry), is more 
often used nowadays in clinics for more convenient IOP measurements.  In this method, 
the cornea curvature is monitored by a light beam with the setup shown in Figure 1-7, 
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while a puff of air is directed to the cornea as the applanation force, similar to contact 
tonometry.  During operation the air-puff pressure is increased until it flattens a 
determined area of the cornea under surveillance through the optical system, and the 
obtained pressure balancing the internal pressure of the cornea can be used to estimate the 
related IOP.  This method allows a large number of measurements in a relatively shorter 
period and more accurate readouts with minimal natural refractory responses from the 
targets during the measurement. 
Figure 1-6: Applanation tonometry. (a) Concept. (b) Illustration of actual implementation. 
Image (a) courtesy of Dr. Kirstein and (b) reprinted from [13]. 
(a)
(b)
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Figure 1-7: Concept of non-contact applanation tonometry. Image reprinted from [12]. 
 Although applanation tonometry is the current clinical standard, it has difficulty in 
achieving faithful IOP readouts because of its indirect measurement nature.  Its 
implementation also causes low precision and low repeatability in common practice, 
especially in the contact scheme.  In addition, difference of dimensions (e.g., corneal 
thickness and curvature) and mechanical properties (e.g., ocular rigidity) in individual 
eyes greatly influence the resultant applanation force/pressure from ocular mechanics [7, 
14, 15], giving a large measurement variation that may cover the accuracy of interest (1 
mmHg).  Moreover, such procedures require care from specialists, implying frequent 
clinic visits and examination, making it less than ideal for regular (e.g., daily) monitoring 
of pressure fluctuations and treatment progress.  As recent findings suggest that IOP 
spikes from diurnal fluctuations should be considered as a separate risk factor to optic 
nerve damage [16–18], new paradigms with continuous IOP tracking capability are being 
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developed for prompt detection and appropriate treatment in order to provide a different 
solution to glaucoma management.  These considerations together articulate the great 
need for a direct, convenient, and reliable continuous IOP sensing technology. 
1.4 Clinical Procedures for Intraocular Pressure Regulation 
 Although elevated IOP is only one of the major risk factors of glaucoma, lowering 
it via pharmaceuticals or surgery is currently the mainstream of effective glaucoma 
treatment [1–5].  To clarify again, these treatments may save a patient’s remaining vision, 
but they can not improve his/her sight already lost from glaucoma.  Current clinical 
procedures comprise medicines, surgeries (laser and conventional), or a combination of 
these.  In the U.S., medications are often first prescribed, while laser surgery is often the 
first line of therapy in Europe, Japan, and Canada. 
In terms of drug therapy, there are several different classes of medications to treat 
glaucoma by lowering IOP, with several different medications in each class (such as 
adrenergic, alpha agonist, beta blockers, carbonic anhydrase inhibitors, cholinergic 
(miotic) and prostaglandin analogs to name a few examples [4]). Each of these medicines 
may have local and/or systemic side effects, as well as potential patient refractoriness to 
the drug composition.  The medication treatment is typically in the form of eye drops 
with dosages depending on the severeness of the disease.  It inherently causes 
prescription difficulty due to the lack of effective diagnosis and efficient dosage style, 
especially at the early detection and treatment stage.  In addition, because glaucoma often 
has no symptoms, people may be tempted to stop taking, or may forget to take, their 
medicine.  As a result, poor compliance with medications and follow-up visits become a 
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major reason for vision loss in glaucoma patients.  Patient education and communication 
must be ongoing to sustain successful treatment plans using drug therapy for this lifelong 
disease with no early symptoms. 
 Surgery therapy involves laser surgery or conventional microsurgery that creates a 
cut in the eye in order to increase the intraocular fluid drainage blocked by neuropathy 
from glaucoma so as to reduce the resultant IOP.  Laser surgery is performed using a 
high-intensity beam of light aiming at the lens and reflected onto the meshwork inside the 
glaucomatous eye.  During operation the laser makes several evenly spaced burns that 
stretch the drainage holes in the trabecular meshwork so that the fluid can be drained 
more effectively.  Conventional microsurgery is utilized when a new fluid drainage path 
needs to be created at the eye, as shown in Figure 1-8 [3].  Depending on different 
surgical locations determined by an ophthalmologist, different surgeries such as 
canaloplasty and trabeculectomy can be performed [5].  These created openings also 
facilitate the fluid being drained out of the eye more effectively.  Overall the surgery 
therapy offers a high success rate (60%–80%) at lowering the IOP.  However, it is only a 
temporary solution and its effects can wear off in the long term as the wound/opening 
will heal over time.  Further treatment, even including repeated procedures, may need to 
be conducted for lifelong glaucoma management, while surgical and post-operative 
complications such as eye infection and inflammation are a serious concern. 
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Figure 1-8: Improvement of intraocular fluid drainage by surgery therapy. Drawing 
courtesy of National Eye Institute. 
 Given that improving intraocular fluid drainage is still the most effective known 
solution to glaucoma treatment and that continuous regulation should be realized to avoid 
fluid re-accumulation, the concept of an artificial drainage path using implants has been 
proposed.  An implant device is positioned at the surgically created drainage opening so 
that the drainage path will remain even when the wound is healed.  This implant therapy 
can achieve the same functionality of lowering IOP as standard surgery therapy, while the 
effective duration of treatment can be extensively prolonged, suitable for lifelong 
glaucoma management.  Generally, such implants or glaucoma drainage devices (GDDs) 
embody a through tube to shunt the fluid in a path similar to that shown in Figure 2-8.  
GDDs have been developed over the last 100 years (since 1907 [19–22]).  State-of-the-art 
examples are shown in Figure 1-9 in non-valved (Molteno and Baerveldt) and valved 
(Krupin and Ahmed) designs, and the typical implantation configuration is represented in 
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Figure 1-10.  The flow tube is inserted into the anterior chamber and the plate is 
implanted at the subconjunctiva (i.e., underneath the conjunctiva) to allow the fluid flow 
out of the eye into a chamber called a bleb.  However, the existing implant therapy faces 
challenge of systematically controlling the fluid outflow.  No set threshold point can be 
reliably achieved for tube shunt opening and closing even in valved implants, leading to 
excessive fluid drainage and hypotony where the IOP drops lower than 5–10 mmHg—
obviously a failure mode in implant operation.  Other than that, surgical/biological 
compliance of these alien devices in the intraocular environment is also a critical issue.  
Possible surgical and post-operative complications include tissue inflammation and 
scarring as well as clogging of the tube implant.  Trade-off appears to be related to the 
size of the implant: The larger the amount of the effective implant volume, the higher 
likelihood of drainage success and length of operation time, but the greater chance of 
accompanied complications.  With these considerations, a new implant paradigm needs to 
be developed for reliable IOP regulation with minimal complications.  Although this 
thesis emphasizes development of implantable MEMS pressure sensors and 
corresponding wireless IOP sensing technology, the concept of a MEMS-implant-based 
approach for continuous and systematic IOP regulation is also proposed in Chapter 2, 
with preliminary experimental demonstrations and verifications presented in Chapter 5 as 
a supplement addressing the feasibility of the proposed solution in light of the 
aforementioned issues and challenges. 
 13  
Figure 1-9: State-of-the-art GDDs. (top row) Single- and double-plate Molteno implants. 
(middle row) Krupin slit valve and Ahmed glaucoma valve. (bottom row) 350 mm2 and 
250 mm2 Baerveldt glaucoma implants. Image reprinted from [22]. 
Figure 1-10: Glaucoma tube shunt implantation. Illustration courtesy of EyeMDLink.com. 
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1.5 Summary 
 This chapter describes the clinical problems of the ocular disease glaucoma and 
its physiological relation with intraocular pressure (IOP) of the eye.  It shows that 
successful glaucoma management is highly dependent on accurate and reliable IOP 
monitoring and regulation.  The clinical diagnosis and treatment procedures presented 
here are effective and widely utilized nowadays, but they may not be sufficient to manage 
this lifelong chronic disease, as studies show that patients can still experience loss of 
vision even in the care of ophthalmologists.  New approaches to continuous/real-time 
IOP monitoring and regulation are therefore needed to improve the current situation so 
that early detection and appropriate treatment of glaucoma can be better managed. 
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CHAPTER 2
MEMS IMPLANT APPROACHES FOR 
INTRAOCULAR PRESSURE 
MONITORING AND REGULATION 
2.1 MEMS Implant Approach for Intraocular Pressure Monitoring 
 In order to fulfill continuous IOP monitoring with high fidelity and high accuracy 
(which is not available using current clinical procedures), information on IOP variations 
must be obtained directly from the inside of the eye and be registered/accessed at all 
times—ideally in a 24/7 fashion to accommodate the concerns of current glaucoma 
detection approaches as described in Chapter 1.  These requirements can be met by 
having a pressure sensor implanted into the eye [1].  As shown in Figure 2-1 for 
illustration, such a sensor paradigm is designed to be secured on the iris under the 
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transparent cornea for the best observation from and communication with the outside 
world.  Because of its placement, the pressure sensor can register in situ IOP variations in 
the anterior chamber of the eye.  An external reader is exploited to interrogate the sensor 
and obtain the direct IOP readouts, with the possibility of autonomous recording 
facilitated by electrical and/or optical transduction from the reader/sensor interaction.  
The sensor implant is the key component and needs to be highly biocompatible in the 
intraocular environment.  Its form factor also needs to be suitable for minimally invasive 
implantation to minimize the complexity of surgical procedures.  It turns out that MEMS 
technology and its derivation parylene MEMS technology (described in the Appendix), is 
the perfect means to address these constraints and ultimately accomplish the proposed 
application.  The developed parylene-based MEMS pressure sensors are designed to be 
totally implantable, with small characteristic dimension so that no sutures are required for 
the corresponding small flat incision (< 2 mm) after the surgery.  They are a passive 
sensing scheme, in contrast to active sensing [2, 3] in which power transfer, hermetic 
packaging, size, and cost of the device are critical concerns.  Major design specifications 
of the proposed sensor implant paradigm to be achieved for practical IOP monitoring are 
listed in Table 2-1.  Depending on different reader implementation, two types of 
parylene-based MEMS sensor implants having specific core micromechanical structures 
for electrical [4] and optical [5] wireless sensing are demonstrated in this work.  Detailed 
device design, fabrication, experimental results, and analysis are presented in the 
following chapters (Chapter 3: electrical sensing; Chapter 4: optical sensing) in order to 
prove the passive sensor implant concept for continuous IOP monitoring.  All associated 
animal procedures and experiments in this study conformed to the ARVO Statement on 
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the Use of Animals in Ophthalmic and Vision Research, and were held to the highest 
ethical standards possible. 
Figure 2-1: Concept of MEMS implant approach for continuous IOP monitoring. (a) 
Surgical placement of the device implant in the intraocular environment. (b) Wireless 
IOP sensing with the use of an external reader interrogating the intraocular implant 
Iris
Cornea
Lens
Pupil
IOP sensor(a)
(b)
Wireless IOP 
readout
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Table 2-1: Design specifications of the proposed sensor implant paradigm                      
for practical IOP monitoring 
Design item Specification 
Pressure sensing accuracy 1 mmHg 
Pressure sensing range 1–50 mmHg
Characteristic length < 2 mm* 
Surgical placement Anterior chamber (iris) 
Biocompatibility Implantable grade 
Sensing method Wireless; passive 
Readout constraint Autonomous or self-checking (free from clinic visit) 
Sensing Distance 
(Implant-reader distance) > 1 cm
†
*Facilitating minimally invasive implantation surgery 
† Incorporating iris-cornea distance (~ 0.5 cm) 
2.2 MEMS Implant Approach for Intraocular Pressure Regulation 
 The interest in utilizing MEMS technology in this work also covers application of 
IOP regulation other than IOP monitoring, in the sense of providing alternative 
approaches to current non-optimal clinical glaucoma management techniques.  MEMS 
technology has been implemented for microfluidics and flow control/transport at the 
microscale for years [6–8].  The form factor and the operation range of these fabricated 
microfluidic devices surprisingly match the required specifications of intraocular fluid 
drainage, enabling their use in implantable microdevices [9].  The MEMS implant 
approach is based on the conventional GDD concept that the device implant is designed 
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to be positioned at the subconjunctiva (as shown in Figure 2-2) in order to create the 
biomimetic drainage path.  The intraocular fluid is drained through the implant to the 
subconjunctiva then eventually diffused away, the same as in the natural drainage path 
previously shown in Figure 1-5.  With micromachining processes the shunt device can be 
fabricated in a tube shape and in a form factor smaller than a hypodermic needle, so that a 
minimally invasive needle-based device implantation scheme can be realized.  The entire 
implant is designed to be placed in the intraocular environment with no exposure to the 
outside world or through the sclera, minimizing the possibility of surgical and post-
operative complications of the implantation.  Designed tissue anchors (not shown in 
Figure 2-2) are integrated on the device implant for its suture-less fixation in the 
intraocular environment.  Because of the small incision size, no sutures would be needed 
after the surgery as the eye will heal spontaneously. 
Figure 2-2: Surgical placement of the MEMS implant (highlighted in red). The small 
arrows indicate fluid drainage direction through the tube implant. Image adapted from 
Figure 1-5. 
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 The flow control behavior of the MEMS implant is accomplished using a 
combination of microchannel and microvalve, as in a typical microfluidic device 
paradiagm.  Because of its sophisticated microflow control in the miniature pressure/flow 
rate regime, this combination can achieve more reliable and more controllable intraocular 
fluid drainage compared to conventional large-scale valved GDDs.  The flow can be 
regulated in a customized pressure-bandpass profile as shown in Figure 2-3, with 
highlighted low-off and high-off threshold characteristics for safety reasons.  For 
example, the artificial drainage path is closed when the IOP is low (e.g., < 10 mmHg) in 
glaucoma patients to prevent hypotony.  It is also closed when IOP spikes (e.g., 50–80 
mmHg) because of routine external interferences, such as rubbing or pressing on the eye, 
to prevent excessive high-pressure high-flow-rate fluid drainage.  Furthermore, this 
drainage path must be proof to any fluid backflow (i.e., from outside to the anterior 
chamber of the eye through the implant) for biological/medical considerations.  These 
features can be further adapted in all biomedical flow controls for safe and effective 
regulation within a range of interest.  This approach is implemented in a passive-valved 
configuration to demonstrate a non-electronic and power-free implant.  The passive 
paradigm is advantageous in many aspects compared with actively powered valves, in 
which design complexity, actuation implementation, power consumption, form factor, 
and/or integration capability is a major concern.  As stated previously, the parylene 
MEMS technology can be applied here as well to pursue fully biocompatible implants 
while achieving required structural and fluidic performance from such micromechanical 
devices.  Major design specifications of the proposed sensor implant paradigm to be 
achieved for practical IOP regulation are listed in Table 2-2.  The correspondingly 
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developed parylene-based MEMS IOP drainage device [10–12] is presented in Chapter 5 
with illustrative description of design, fabrication, and experimental results, in order to 
prove the concept for continuous IOP regulation.  Same with the pressure sensors, all 
associated animal procedures and experiments in this study regarding the drainage 
devices conformed to the ARVO Statement on the Use of Animals in Ophthalmic and 
Vision Research, and were held to the highest ethical standards as possible. 
Figure 2-3: Proposed IOP regulation profile of the MEMS implant. The slope in flow 
conductive region is determined by the practical fluidic resistance of the device. 
Table 2-2: Design specifications of the proposed device implant paradigm                      
for practical IOP regulation 
Design item Specification 
Regulated pressure range 10–15 mmHg 
Drainage flow rate 1–10 ?L/min-mmHg 
Regulation method Spontaneous; passive 
Characteristic length < 0.5 mm* 
Surgical placement Subconjunctiva 
Biocompatibility Implantable grade 
*Facilitating needle-based minimally invasive implantation surgery 
Pressure0
Flow rate
Cut-off pressureThreshold pressure
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2.3 Summary 
 This chapter delivers the concept of utilizing MEMS-based implant paradigms as 
alternative approaches to current clinical techniques with the intent of providing accurate, 
reliable, and continuous/real-time IOP monitoring and regulation toward glaucoma 
detection and drainage.  Enabled by MEMS technology and the use of biocompatible 
polymeric parylene material described in the Appendix, the microfabricated implants can 
be developed for such ophthalmic applications, including wireless passive IOP sensors 
with an electrical sensing method presented in Chapter 3, and with an optical sensing 
method presented in Chapter 4.  In addition to the IOP sensing technology, investigations 
on passive microfluidic IOP drainage devices are also described in Chapter 5 to convey 
device feasibility and future possibility.  These biocompatible, unpowered, 
micromechanical MEMS implant paradigms are designed to have surgical/biological 
compliance for minimally invasive implantation and long-term operation in the 
intraocular environment, as well as ultimately more effective and reliable glaucoma study 
and management compared with current state-of-the-art medical technologies. 
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CHAPTER 3
IMPLANTABLE PARYLENE-BASED 
INTRAOCULAR PRESSURE SENSORS 
WITH ELECTRICAL READOUTS 
3.1 Overview 
This chapter presents an implantable, unpowered, parylene-based wireless MEMS 
pressure sensor for continuous IOP monitoring in an electrical sensing paradigm.  It has 
an electrical LC-tank resonant circuit formed by an integrated capacitor and an inductor 
coil to facilitate passive wireless sensing with the use of an external interrogating coil on 
a reading apparatus.  The first version of the surface-micromachined sensor is in two 
designs involving variable capacitor and variable capacitor/inductor resonant circuits to 
realize the pressure-sensitive components.  The sensor is monolithically microfabricated 
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by exploiting parylene as a biocompatible structural material in a suitable form factor for 
minimally invasive intraocular implantation.  Pressure responses of the microsensor have 
been characterized on-chip to demonstrate its high pressure sensitivity in both sensor 
designs.  A 6-month animal study verifies the in vivo bioefficacy and biostability of the 
sensor implant in the intraocular environment with no surgical or post-operative 
complications.  After incorporating improvements of sensor design and readout method, 
the second version of the device implant successfully meets engineering and surgical 
specifications with enhanced performance for practical IOP measurements through on-
bench and in vivo experimental verifications.  This sensor will ultimately be implanted on 
the iris of the eye to fulfill continuous, convenient, direct, and accurate IOP monitoring. 
3.2 Implant Design 
3.2.1    Background 
 Passive telemetric sensing has been widely used as one of the viable methods to 
accomplish continuous and accurate non-contact IOP measurements [1, 2].  This 
methodology enables straightforward IOP sensing by utilizing a transensor implant that 
registers environmental pressure variations inside the eye, so that the IOP can be directly 
measured by using an external reader wirelessly interrogating the implant.  In contrast to 
active sensing in which power transfer, size, and cost of the device are critical concerns 
[3, 4], passive telemetric sensing has relatively flexible design considerations on the 
device side [5].  The first paradigm using this sensing method was reported in 1967 [6] 
when a capsulated sensor having an electrical LC-tank resonant circuit was implanted to 
the anterior chamber of the eye for IOP monitoring.  With recent progress in 
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microelectromechanical systems (MEMS) technology, miniaturized pressure sensors [7–
11] (such as those shown in Figure 3-1) have been developed using the LC resonant 
circuit concept and the enabling microfabrication technologies for various wireless 
sensing of physiological parameters: including transcutaneous pressure monitoring, 
intracranial pressure monitoring, and pressure monitoring of abdominal aortic aneurysms 
(AAA), in addition to the proposed IOP monitoring application. 
Figure 3-1: Wireless passive MEMS pressure sensors for physiological parameter 
measurements in literature. (a) Device for IOP sensing [6]. (b) Device for IOP sensing [7]. 
(c) Device for transcutaneous pressure sensing [9]. (d) Device for aortic aneurysms 
pressure sensing [11] 
(a)
(b)
(c) (d) 
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These reported devices serve as excellent examples showing the potential for 
using such wireless passive pressure transensors for continuous measurement of 
physiological parameters in biomedical systems and human healthcare.  The theory and 
model of wireless LC sensing have been well established, given the development of these 
reported pressure microsensors.  On the technology side, however, all these MEMS 
devices to date involve delicate multiple wafer fabrication procedures, with wafer 
bonding as the essential process to create the pressure-sensitive chamber of the variable 
capacitor.  This creates challenges in adapting them to intraocular implants due to the 
small available space in the anterior chamber of the eye.  Consequently, by exploiting 
parylene in integrated surface-micromachined capacitive sensors [12], a monolithically 
microfabricated parylene-based wireless passive pressure sensor is developed having a 
form factor suitable for minimally invasive device implantation and placement at the pars 
plana or on the iris of the eye.  Along with engineering specifications, design 
considerations are also focused on compatibility with surgical procedures to minimize 
complexity and time of operation for ease of device implantation in practice.  Featuring 
parylene as the biocompatible polymeric material, the pressure sensor is designed to be 
completely implantable in the intraocular environment so that long-term continuous IOP 
monitoring of glaucoma patients becomes practical. 
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3.2.2    Sensing scheme 
The concept of the wireless IOP sensing system in the passive electrical sensing 
scheme is shown in Figure 3-2, and the associated glasses-type reader paradigm is 
proposed as shown in Figure 3-3 for autonomous and continuous monitoring in practice.  
The sensor implant is designed to have an electrical LC-tank resonant circuit with a 
corresponding resonant frequency represented as 
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where Ls, Cs, and Rs are respectively the inductance, capacitance, and resistance of the 
sensor.  Using an external coil to build an inductive coupling link with the implanted 
sensor, the equivalent impedance viewed from the measurement instrument can be 
derived using circuit analysis as [11–13] 
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where V and I are the exciting voltage and current across the reader coil, f is the 
excitation frequency, Qs = Rs-1(LsCs-1)1/2 the quality factor of the sensor at resonance, and 
k is the coupling coefficient of the inductive link (totally dependent on physical 
geometries such as the planar size of the sensor and reader coils, and the separation 
distance between the coils [9–13].  Therefore, from (3.2), a phase-dip technique can be 
applied to wirelessly detect the resonant frequency of the sensor as the phase of the 
complex impedance Zeq drops to the minimum in the frequency scan from the 
(3.2)
(3.1)if 
,
,
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measurement instrument—such as an impedance analyzer, network analyzer, or other 
involving customized electronics.  When the sensor is excited at resonance, Zeq becomes 
? ?22 1eq s r sZ j f L jk Q?? ?
and its phase dip magnitude can be approximated as 
? ?1 2tan sk Q? ?? ?
As long as the impedance phase dip is detectable in the frequency scan, the 
resonant frequency of the sensor can be accurately characterized.  As a result, if the 
sensor implant has pressure-sensitive electrical components, its resonant frequency will 
be shifted based on external pressure variation, thus registering the in situ environmental 
pressure.  This change can be interrogated using the external reader coil to accomplish 
continuous wireless IOP monitoring. 
Figure 3-2: Passive wireless IOP sensing concept. The implanted sensor can faithfully 
register pressure variations using corresponding electrical characteristic changes, which 
are measured using an external reader through a wireless inductive coupling link. 
(3.3),
(3.4).
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Figure 3-3: Proposed IOP monitoring in practice. (a) Autonomous and continuous 
sensing using glasses reader paradigm. (b) Integrated reader components on the frame 
3.2.3    Sensor design 
The pressure sensor is designed as illustrated in Figure 3-4 to facilitate the passive 
wireless pressure sensing scheme.  It comprises a flexible diaphragm chamber integrated 
with parallel metal plates as an integrated capacitor and surrounding metal wires as a 
planar inductor to create the resonant circuit that communicates with the external reader.  
A dual-layer metal structure is employed to increase the overall inductance of the coil in 
the given device area.  In the surgical design aspect, the device has a rectangular in-plane 
contour to minimize the required incision size during implantation, along with smooth 
edges to prevent tissue irritation in the intraocular environment.  Suture holes are located 
at both ends of the device for convenience in implant anchoring. 
Figure 3-4: Pressure sensor design (top view).  The flexible diaphragm on top of the 
device area as the movable structure is not shown in this planar illustration. 
Planar inductor 
Reader coil(a) (b) 
Readout/storage
electronics
Device insulation layer Device substrate Suture holes 
Pressure access holes  
for the diaphragm 
Parallel-plate
capacitor
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In the engineering design aspect, the electrical characteristics of the sensor can be 
determined by using the following equations [8, 14, 15].  The inductance of the dual-
layer planar inductor in rectangular conformation can be calculated as 
, , 2s s top s botL L L M? ? ?
where Ls,top and Ls,bot are inductances, respectively, from top and bottom metal layers as 
? ? ? ? ? ?
? ?
? ?? ?
2 1 2
, , 1 2 1 1 2 2
1 22
1 2
20.02339 log log log
                       0.01016 2 0.447
2
                       0.01016
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nD
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where n is the number of turns of the inductor, s1 and s2 are the average lengths of two 
sides of the inductor (in), 2 21 2g s s? ?  (in), D is the distance of the planar metal line 
separation plus metal line width (in), and A and B are constant coefficients determined by 
the winding geometry and the number of turns of the coil.  The mutual inductance M is 
generated by intrinsic magnetic coupling between the top and bottom metal wires of the 
inductor and can be calculated as 
20.00254 2.303log 1l gM l
g l
? ?? ?
? ? ?? ?? ?
? ?? ?
where l is the total length of the dual-layer metal wires (l/2 for each layer) (in), and g is 
the separation distance between the top and bottom metal layers of the inductor (in).  The 
integrated inductor imperatively has a series resistance dominating Rs, and its value with 
consideration of the high-frequency skin effect can be calculated as 
, (3.5)
(3.6)
(3.7)(?H)   if l >> g , 
(?H) , 
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where ? is the electrical resistivity of the metal, w and h are the metal line width and 
height, respectively, and ? is the frequency-dependent metal skin depth given by 
f
??
? ?
?
where ? is the magnetic permeability of the metal.  Finally, the capacitance of the sensor 
can be expressed as 
, ,s s g s pC C C? ?
where Cs,g is the capacitance determined by the integrated parallel metal plates with a gap 
separation at center of the sensor, and Cs,p is the parasitic/stray capacitance generated by 
the other components in the entire device.  It is clear from (3.5)–(3.7) and (3.10) that the 
electrical characteristics of the sensor can vary with respect to geometrical changes in the 
movable structures.  Therefore, a deformable free-standing diaphragm embedding 
electrical components is employed to realize the transensor device.  The deformation 
profile of a rectangular diaphragm with four fixed edges under a pressure loading can be 
estimated as in [16], where in the case of small deflection the maximum diaphragm 
deformation at the center can be calculated by [17]
4
1
max
? ?
? ?? ?
? ?
C ay P
D
where ?P is the pressure difference across the diaphragm, a is half the length of the short 
edge of the rectangular diaphragm, D = Et3 / [12(1-?2)] the flexural rigidity of the 
(3.8),
, (3.9) 
, (3.10)
(3.11),
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diaphragm in which E is Young’s modulus and ? is Poisson’s ratio of the material, t is the 
diaphragm thickness, and C1 is a constant coefficient determined by geometry and 
boundary conditions of the diaphragm.  In a large deflection case where the assumption    
(y << t) is not valid, ymax is calculated using the load-deflection relationship as [18, 19] 
332
max max2 4
? ? ?? ? ? ? ?? ? ? ?? ? ? ?
C EtC t y y P
a a
where ? is residual stress of the diaphragm, and C2 and C3 are constant coefficients 
determined by geometry and material property (Poisson’s ratio) of the diaphragm.  
Incorporating such an electrical-mechanical-coupled effect, a pressure-sensitive variable 
capacitor can be realized, as shown in Figure 3-5, by arranging the bottom plate on the 
substrate and the top plate in the diaphragm.  Additionally, instead of having a fixed 
inductor surrounding the variable capacitor, a variable inductor can be realized by 
embedding the top metal wire layer in the diaphragm to alter the intrinsic mutual 
inductance of the dual-layer inductor for further enhanced overall pressure sensitivity.  
These two sensor designs are implemented on a monolithic substrate with the use of 
surface-micromachining technology, so as to have less fabrication complexity compared 
with wafer bonding technology.  The pressure reference can be encapsulated inside the 
diaphragm chamber after sealing the backside of the device at a constant pressure for 
gauge pressure sensing.  All device structures—including oxidized and parylene-coated 
silicon substrate, titanium/gold metal lines and plates, and the flexible parylene 
diaphragm—have sufficient biocompatibilty to ensure the feasibility and reliability of 
long-term operation of the device implant in the intraocular environment.  The dielectric 
behavior of parylene (dielectric constant ~ 2.95 at 1 MHz) also favors its use as an 
(3.12),
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insulator between metal layers.  Given the aforementioned models and materials, the 
overall sensing performance can be estimated to meet the required specification of minute 
pressure variation measurement (±1 mmHg) for accurate IOP monitoring. 
Figure 3-5: Sensor design (cross-sectional view; not to scale) in variable capacitor (top) 
and variable capacitor/inductor (bottom) variations. The deformable diaphragm chamber 
with respect to pressure changes realizes pressure-sensitive characteristics of the sensors. 
3.3 Device Fabrication 
The fabrication process of the wireless pressure sensor is illustrated in Figure 3-6.  
It began with thermally growing and patterning 0.75-μm-thick oxide on a double-side-
polished (DSP) silicon wafer using buffered hydrofluoric acid (BHF, Transene Company 
Inc., Danvers, MA) and photoresist as the mask.  AZ series photoresist (Clariant Corp., 
Charlotte, NC) was used in this step and in the rest of the microfabrication processes.  
The frontside oxide insulates the surface-micromachined structures from the silicon 
substrate, and the backside oxide defines the recess and release boundaries of the device.  
Dual-layer  
metal wires 
Parallel metal 
plates
Flexible diaphragm 
chamber 
CsLs
Rs
CsLs
Rs
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A titanium/gold (200 Å/2 μm) layer was deposited using e-beam evaporation and 
patterned using standard metal etching techniques to form the bottom half of the 
electrical components of the sensor.  Thick metals are preferred in order to reduce the 
overall electrical resistance of the metal lines.  Although metals with higher thickness 
could be deposited using electroplating, evaporated metals were used because of their 
superior material quality for implant use and fabrication compatibility with subsequent 
surface-micromachining processes.  A parylene layer was then coated on the bottom 
metal of the sensor in the variable capacitor design for insulation purposes between the 
dual-layer metal wires, while an air gap was used for the sensor in variable 
capacitor/inductor design.  Parylene deposition was conducted in a PDS 2010 
Labcoater™ system (Specialty Coating Systems, Inc., Indianapolis, IN).  A via for metal 
contact was created in the parylene layer after patterning it using oxygen plasma and 
photoresist as the mask.  A sacrificial layer of photoresist was then coated and patterned 
on the wafers so as to define the enclosed space of the pressure-sensitive diaphragm 
chamber.  Gas-phase xenon difluoride (XeF2, Nesca Corp., Pretoria, South Africa) silicon 
roughening was preformed for physically strengthened adhesion between the final 
surface-micromachined structures and the substrate [20].  Afterwards, sandwiched 
parylene-metal-parylene layers were deposited and patterned, including another e-beam-
evaporated titanium/gold (200 Å/0.5 μm) layer to realize the flexible diaphragm 
chambers with variable capacitor or variable capacitor/inductor structures by having 
different patterns of the sacrificial photoresist layer in different sensor designs.  Finally, 
the devices were released after performing a silicon deep-reactive-ion etching (DRIE) in 
a PlasmaTherm™ SLR system (Unaxis Inc., St. Petersburg, FL) on the backside of the 
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wafer, followed by photoresist stripping with acetone.  Backside recesses and through-
holes as necessary features were also created after DRIE.  Supercritical carbon dioxide 
(CO2) drying in an Autosamdri-815™ system (Tousimis Research Corp., Rockville, MD) 
was used to eliminate stiction of the free-standing parylene-metal-parylene diaphragm.  
Figure 3-7 shows the microfabricated parylene-based pressure sensors in both designs, in 
a form factor smaller than 4 mm × 2 mm × 1 mm, suitable for intraocular implantation. 
(a)          (b) 
Figure 3-6: Fabrication process flow of microsensors. (a) Variable capacitor design. (b) 
Variable capacitor/inductor design 
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(a)                 (b)         (c) 
Figure 3-7: Images of microfabricated devices. (a) Full-scale photograph of the sensors 
(top view). (b) SEM image of the sensor (cross-sectional view). (c) Micrograph of the 
sandwiched metal-parylene-metal structure showing the inductor wiring and the via (top 
view). (b) and (c) are images of the sensor in variable capacitor design as example. 
In order to achieve both successful device release and packaging, a special two-
step etch mask consisting of oxide and photoresist was used for the backside DRIE.  By 
controlling the heights of this two-step mask and the associated etch time, a backside 
recess was formed on the substrate along with through-wafer etches at locations of the 
photoresist release holes beneath the parylene diaphragm chamber, the end suture holes, 
and the release boundaries of the device.  The backside recess enables gauge pressure 
sensing of the devices.  For gas-sealed MEMS gauge pressure sensors, the change of 
encapsulated pressure reference due to diaphragm defection and corresponding change of 
volume should be considered [21], as illustrated in Figure 3-8.  Derived from the ideal 
gas law, the increase of the pressure reference can be written as [10] 
0 0
0
? ? ?
??
nRTP P
V V
Variable C: 4 mm×2 mm (planar) 
Silicon-roughened trench
Parylene diaphragm
Metal wires
20 ?mVariable C&L: 4 mm×1 mm (planar) 
(3.13),
50 ?m
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where n is the number of moles of gas/air particles, R is the universal gas contant, T is the 
environmental temperature, ?V is the magnitude of change of volume, and V0 and P0 are 
the originally encapsulated volume and pressure of the sensor.  As a result, the change of 
reference pressure would influence the diaphragm defection and the resultant pressure-
sensing behavior, thus it needs to be reduced if it is comparable with the pressure 
difference to be measured.  For the microsensors fabricated in this work, a large gas 
volume can be encapsulated inside the device after sealing the 250-μm-deep backside 
recess in addition to that from the surface-micromachined diaphragm chamber, which 
effectively increases the resultant pressure sensing capacity after packaging. 
(a)
(b)
Figure 3-8: Volume change effect in gas-sealed MEMS gauge pressure sensors. (a) The 
encapsulated gas volume and pressure is variable due to diaphragm deformation. (b) 
Method to reduce such effect by attaching the sensor back-to-back to a non-electric piece 
to increase the reference volume V0 (variable capacitor design as example). 
P0 , V0
P = P0
P0 + ?P0 , V0 – ?V
P > P0
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For demonstration purposes, the fabricated sensor device in this work was 
attached back-to-back to a non-electronic parylene-coated silicon piece with identical 
geometrical dimensions under atmospheric pressure (1 atm) at room temperature.  The 
influence on pressure sensing from such volume change effect could then be controlled to 
less than 100 ppm/mmHg, insignificant compared with the results from designed 
compliant diaphragm deflections.  The overall device thickness can definitely be trimmed 
by thinning down the silicon pieces during fabrication to result in a smaller device size if 
required.  After packaging, a thin conformal parylene layer was selectively coated on the 
entire device to enhance its biocompatibility for medical use. 
3.4 Characterization Results 
The microfabricated devices were tested on-bench, ex vivo, and in vivo to 
characterize their electrical, physical, and surgical/biological behaviors.  During testing a 
HP 4195A network/spectrum analyzer (HP/Agilent Technologies Inc., Santa Clara, CA) 
under standard settings was utilized in connection with a 1.5-mm-diameter hand-wound 
coil made out of standard insulated copper wire to serve as the external reader for the 
wireless sensing demonstration.  Measured equivalent impedance spectra data were 
stored in a personal computer using the LabVIEW™ program (National Instruments 
Corp., Austin, TX) for pressure measurement analysis.  Testing results are described in 
the following sections. 
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3.4.1    Electrical characterization 
Electrical parameters of the sensors were first obtained by analyzing the 
measurement data from both the actual devices with the external readout method and 
several testing structures through on-chip probing.  Table 3-1 lists the experimental 
results, which were in good agreement with theoretical calculations.  The resistance, 
inductance, and capacitance of the sensor in variable capacitor design were all higher 
than that of the sensor in variable capacitor/inductor design due to a larger device area.  
The dual-layer metal wires in proximity across the parylene dielectric in the variable 
capacitor design gave substantial stray capacitance to the sensor. 
Table 3-1: Measured electrical parameters of the microfabricated pressure sensors 
Variable C Variable C&L 
Inductance 0.78 μH 0.36 μH 
Capacitance 7.4 pF 3.1 pF 
Resistance at resonance 112 ? 72 ?
Resonant frequency ~ 62 MHz ~ 150 MHz 
Quality factor ~ 3 ~ 5 
Although the low quality factor (Qs < 10) and small integrated coil size of the 
sensors fundamentally limits the sensing distance of the wireless system, the sensor 
signal was still detectable (as shown in Figure 3-9), which validates the feasibility of the 
impedance phase-dip measurement technique as the sensing scheme.  Being different 
from the ideal case, the phase of the impedance Zeq dipped to the minimum at the 
frequency fmin, which is highly correlated to fs and can be expressed as [13] 
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while the discrepancy was less than 1% given the negligible term from the small coil 
coupling coefficient effect compared with the term from the quality factor effect in this 
work.  The maximum sensing distance where the phase dip ?? < 0.1°, determined by the 
noise floor from the testing system, was confirmed to be approximately 2 mm for both 
sensor designs. Other than reader optimization, the following strategies directly related 
to sensor development can be implemented to improve the sensing distance and should be 
included: 1) increase the integrated coil size and the planar geometry (k ?); 2) increase 
the metal wire thickness (Rs ?); 3) increase the insulating oxide thickness and/or modify 
the substrate material (Cs ?); and 4) include ground shield patterns [22] which can be 
potentially utilized as inductor interlayer shield patterns (Cs ?). 
Figure 3-9: Representative captured frequency scan of the equivalent impedance Zeq of 
the reader coil coupled with the microsensor 
Impedance phase
?Zeq (deg) 
|Zeq| (?)
fmin f (MHz)
Impedance magnitude 
, (3.14)
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3.4.2    On-bench pressure sensing test 
After electrical characterization the sensors were tested on-chip to measure their 
pressure responses.  Pressure differences were generated by supplying pressurized air to 
the inside of the sensor diaphragm chamber through a customized packaging jig 
connected to a controllable pressure regulation system (as shown in Figure 3-10) with 
constant environmental pressure outside the diaphragm chamber.  A commercial off-chip 
pressure regulator and a pressure gauge were used to control the pressurization with 0.5 
mmHg tuning resolution.  The external reader coil was aligned above the packaged 
device on the same axis using a manipulation stage for in situ wireless sensing.  This 
testing configuration was applied to condition the sensors for testing convenience without 
losing the fidelity of the sensor performance because the volume change effect can be 
neglected given the fabricated device dimensions. 
Figure 3-10: On-bench pressure testing setup for device characterization 
Pressure source 
Pressure regulator 
Pressure gauge 
Device packaging 
jig with exposure to 
external reader coil 
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Experimental results, as shown in Figure 3-11, successfully verified the feasibility 
of wireless pressure sensing with the sensor in variable capacitor design as an example.  
The phase-dip plots indicate that, as the pressure inside the diaphragm chamber increases, 
the diaphragm is deformed outward and moves the embedded metal components away 
from the bottom substrate, leading to a decrease in the overall capacitance/inductance and 
an increase in the resonant frequency of the sensor. 
Figure 3-11: Overlay plot of measured phase-dip curves of the sensor (variable capacitor 
design as example) in on-bench wireless pressure sensing. ?P = Pinside sensor – Poutside sensor .
For the sensors in variable capacitor design, the normalized shifted resonant 
frequency can be written as 
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where ?Cs is the changed capacitance due to diaphragm deflection.  It can be further 
derived to 
? ? 1min 2
min
( ) 1
( 0)
f P y
f P
?? ? ?
? ?
where ? is a constant coefficient based on material properties and physical dimensions of 
the device.  Assuming small diaphragm deflection which is proportional to pressure 
difference by (3.12), the relationship can be finally derived to 
? ? 1min 2
min
( ) 1 '
( 0)
f P P
f P
?? ? ? ?
? ?
where ?' is a parameter incorporating the mechanical behavior of the diaphragm.  For the 
sensors in variable capacitor/inductor design, the normalized shifted resonant frequency 
can be written as 
? ?? ?min
min
1
2( ) 1 11( 0)
2
s s s s s s
s s
s s
L L C C L Cf P
f P C C
L C
?
?
?? ?? ? ?? ? ? ? ?
? ?
where ?Ls is the changed inductance due to diaphragm deflection.  Similar procedures 
can be used with the small deflection assumption to derive the dependency of the 
normalized shift resonant frequency on pressure difference as 
? ?
1
2
2min
1 2
min
( ) 1
( 0)
f P P P
f P
? ?? ? ?? ? ? ? ?? ?? ?
where ?? and ?? are parameters incorporating coupled capacitance and inductance 
variations from the mechanical behavior of the diaphragm, implying more sensitive 
pressure response from this design.  The measurement results from the sensors in both 
?Ls << Ls
?Cs << Cs
,
,if 
,
(3.16)
, (3.17)
(3.18)
(3.19)
 50  
designs shown in Figure 3-12 were well fit using (3.17) and (3.19) in 0–30 mmHg 
pressure operation range.  Data analysis confirmed that the microfabricated sensors 
achieved excellent pressure-sensing performance with high sensitivities (> 7,000 
ppm/mmHg), providing readouts with resolutions smaller than 1 mmHg so as to 
sufficiently cover all pressure variations of interest for practical IOP monitoring.  Highly 
sensitive pressure responses were obtained based on high compliance of the parylene 
flexible diaphragm and high resonant frequency of the sensors.  In spite of its smaller 
parylene diaphragm, the sensor in the variable capacitor/inductor design has comparable 
sensitivity result with that in the other design, showing the possibility of using devices in 
a smaller form factor while achieving the required sensing performance.  Corrections 
would need to be made on (3.17) and (3.19) to accommodate large diaphragm deflections 
by (3.12) if the diaphragm experiences large pressure loadings, as this pressure-
sensitivity-reduced effect can be observed in Figure 3-11, where the shift of phase-dip 
frequency was smaller when the applied pressure difference was closer to 50 mmHg.  
Table 3-2 summarizes several important characteristics of the microfabricated wireless 
pressure sensors presented in this work 
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Figure 3-12: On-bench pressure testing results of the sensors. (a) Sensor in variable 
capacitor design. (b) Sensor in variable capacitor/inductor design 
Table 3-2: Measured characteristics of the microfabricated pressure sensors 
Variable C Variable C&L 
Planar dimensions 4 mm × 2 mm 4 mm × 1 mm
Resonant frequency ~ 62 MHz ~ 150 MHz 
Quality factor ~ 3 ~ 5 
Pressure sensitivity 7495 ppm/mmHg 7595 ppm/mmHg 
Pressure responsivity 0.47 MHz/mmHg 1.14 MHz/mmHg 
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3.4.3 Ex vivo pressure sensing test 
 The pressure sensor was implanted into an enucleated porcine eye, as shown in 
Figure 3-13, in order to demonstrate acute ex vivo pressure sensing characterization.  The 
microfabricated sensor was placed under the cornea so as to have the best proximity to 
the external reader coil.  Hence, a corneal flap incision was made with the use of sutures 
to restore environment to an enclosed intraocular space after implantation.  A catheter 
was then inserted to the eye model interfacing with an external infusion-based 
pressurization setup to simulate a situation of IOP variation.  Although not ideal, the 
experimental results shown in Figure 3-14 demonstrated the feasibility of using this 
microsensor for wireless pressure sensing in such an isolated environment.  The 
measured phase-dip frequency of the equivalent impedence dropped more than 15% as 
the sensor implant experienced a substantial environmental permittivity change in the 
liquid medium as compared with air [13].  The measurement noise in the plots resulted 
from the close proximity of the reader coil to the cornea necessary for interrogating the 
implant given the short sensing distance, and could be greatly improved by having a 
longer sensing distance from stronger sensor-reader coil coupling.  The results revealed 
another issue: it was difficult to characterize the pressure sensitivity in this testing setup 
because stable pressure control was not achieved due to protocols in place at the time of 
surgery.  For more systematic ex/in vivo pressure sensing studies, development of 
surgical procedures and tools having improved compatibility with be another focus of 
future work. 
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(a)             (b) 
Figure 3-13: Ex vivo device testing to demonstrate the wireless pressure sensing behavior 
of the sensor implant. (a) Test model with the sensor inside the eye. (b) Wireless sensing 
with the external coil placed in front of the eye model 
Figure 3-14: Overlay plot of measured phase-dip curves of the sensor (variable capacitor 
design as example) in ex vivo wireless pressure sensing. The small arrows indicate the 
phase-dip shift with respect to the simulated IOP increase. 
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3.4.4 In vivo implantation test 
In vivo device implantation testing was conducted using live rabbit eyes as the 
model to evaluate the bioefficacy and biostability of the sensor implant.  The fully 
packaged microdevices with the bottom sealing piece were sterilized using ethylene 
oxide gas and implanted at the pars plana site in the eyes of two rabbits.  A small 2-mm 
angled razor blade incision was made to insert the implant into the eye.  Clinical 
procedures utilizing the end suture holes of the devices were developed to facilitate fast 
and robust device anchoring during implantation.  The operation could be completed 
within 15 min, curtailing occurrence of surgical complications.  Long-term follow-up 
observation, with result photographs shown in Figure 3-15, verified implant 
biocompatibility, as no post-operative complications appeared in the intraocular 
environment.  Given these results as the basis, further improvements of such an implant 
paradigm were performed as described in the following section. 
(a)                           (b) 
Figure 3-15: Follow-up study results of in vivo device testing using rabbit model to verify 
long-term biocompatibility of the intraocular implant. (a) 3 months after surgery. (b) 6 
months after surgery. The arrows indicate the implant as observed through the cornea. 
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3.5 Improvement Strategies and Results 
In spite of successful wireless pressure sensing demonstration, the sensing 
distance of the entire sensor-reader system was not sufficient, especially when 
considering the ultimate glasses-to-iris distance in practice, and thus needs further 
improvement.  Because the entire sensing scheme is based on impedance measurement 
given by (3.3), efforts can be made to increase the measurement sensitivity to obtain a 
more distinguished phase dip, so that the corresponding sensing distance can be enhanced.  
Accordingly, separate strategies can be applied to 1) increase the magnitude of the real 
term, which involves sensor improvement, or 2) decrease that of the imaginary term, 
which involves reader improvement, to enhance the sensing performance.  This work 
focuses on improvement of sensor design for electromagnetic coil coupling and 
resonance quality factor enhancements, followed by the improvement of readout method 
for noise reduction and signal-to-noise ratio (SNR) enhancement in actual wireless 
measurements.  These modifications have been implemented as described in the 
following sections to experimentally verify their effect on increasing the overall sensing 
distance of such a telemetric system for practical IOP monitoring. 
3.5.1    Improved sensor design and fabrication 
In terms of sensor improvement, both the quality factor and integrated coil size 
should be increased as much as possible in order to increase the k2Q factor in (3.4).  
Another flexible-coiled microsensor prototype was created to prove this concept.  Its 
design, illustrated in Figure 3-16, features a larger circular disk substrate to incorporate a 
larger spiral inductor.  The disk diameter was designed to be 4 mm, fitting the iris rim 
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width in normal conditions, and the disk was made out of parylene C with sufficient 
mechanical flexibility so as to maintain a small required incision (< 2 mm) during device 
implantation.  This flexible/foldable coil disk was monolithically microfabricated in 
integration with a bottom rigid silicon substrate in a suitable form factor smaller than 4 
mm × 1.5 mm for ease of handling and realization of the parallel-plate variable capacitor.  
Because this prototype also needs another attachment piece to realize the pressure 
reference in gauge pressure sensing, surgical features were directly created on the non-
electronic sealing silicon piece for suture-less implant fixation on the iris.  
Electrical/mechanical design, material selection, and micromachining processes of the 
pressure-sensitive resonant circuit structures were analogous to those previously 
described, with more intuitive equations applicable to calculate inductance of the circular 
spiral coil.  For example, the inductance of such a coil can be calculated as [15] 
2
0 avg 1 22
3 4ln2
? ? ?? ?? ? ?? ?? ?? ?? ?
n d c cL c F c F
F
where n is the number of turns of the inductor, davg is the averaged diameter of the coil 
windings, F = (dout – din) / (dout + din) the fill factor of the coil windings, and c1–c4 are 
constant coefficients determined by the winding geometry.  The resistance and 
capacitance of the sensor can be determined by the same relations in (3.8)–(3.10).  
Besides the electrical behavior, the mechanical behavior of the parallel-plate variable 
capacitor was determined by (3.11) specifically in the small deflection regime to better 
estimate the pressure-sensitive performance of the micro-electro-mechanical device.  By 
incorporating this theoretical model into sensor design, the thicknesses of the first layer 
metal line (3 ?m) and the sandwiched parylene (8??m)-metal (0.5 ?m)-parylene (8 ?m) 
, (3.20)
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structures were substantially increased in order to facilitate better electrical/structural 
behavior of the microsensor.  Moreover, besides being used to create the top parallel 
capacitor plate, the second metal layer was arranged to be with all boundaries of the 
pressure-sensitive parylene diaphragm chamber in order to effectively serve as a barrier 
to water vapor and gas transmissions/permeations in between the encapsulated air/gas 
and the ambience of the device [23].  It prevents them from substantial performance drift 
and guarantees their long-term operation in the intraocular environment. 
Figure 3-16: Pressure sensor design with flexible parylene coil disk (top view). The 
bottom silicon substrate and the pressure-sensitive flexible diaphragm are not shown in 
this planar illustration. 
 The fabrication process of the modified wireless pressure sensor illustrated in 
Figure 3-17 is comparable to that described in Section 3.3.  As previously stated, the 
deformable diaphragm was created by parylene-metal-parylene layers, including all 
Flexible/foldable
parylene disk substrate
Pressure-sensitive
variable capacitor 
Spiral inductor
Bridging metal line to 
connect inductor wire 
and top capacitor plate
Pressure access hole for
the diaphragm chamber
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sidewalls, so as to minimize liquid/gas permeation from/to the encapsulated air cavity.  
Figure 3-18 shows the microfabricated flexible parylene-based sensors. 
Figure 3-17: Fabrication process flow of modified flexible-coiled microsensor.  The 
arrows indicate the outcome of device release after microfabrication processes. 
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Figure 3-18: Full-scale image of the modified flexible-coiled microsensor with its top 
(left) and bottom (right) views. The diameter of the flexible coil disk was 4 mm. 
After packaging the sensor with a non-electronic piece on the bottom for pressure 
reference, the overall size was measured at ??4 mm × 1 mm and reduced to a form factor 
of 4 mm × 1.5 mm × 1 mm by folding the coil disk as shown in Figure 3-19, still suitable 
for minimally invasive intraocular implantation.  Given the high yield strain (~ 3%) 
characteristic of parylene C, the flexible disk could be stretched back to circular shape 
without severe permanent deformation after this extent of folding. 
          
Figure 3-19: Device flexibility demonstration. The device width could be reduced to 1.5 
mm (predetermined by bottom silicon substrate) when folded (left), then stretched back 
after folding (right) without permanent deformation or other severe damages. 
1 mm
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3.5.2    Improved readout method design and implementation 
Even though the modified sensor design was implemented, it is still not sufficient 
for achieving the required sensing distance when using the primitive readout method, as 
previously described, due to high noise from the actual testing system.  Photographs of 
the captured frequency scans shown in Figure 3-20 indicate that the signal strength of the 
detected phase dip decreases as the sensing distance increases due to the decreased 
inductive coupling between sensor and reader coils. With this effect the maximum 
sensing distance can be defined as where the phase dip signal is lower than the noise floor, 
and is thus undetectable.  Using the aforementioned measurement setup, a ?? ~ 0.1° 
noise was obtained, and the corresponding maximum sensing distance is characterized to 
be only approximately 1 cm with the optimized size of the reader coil.  However, phase 
change can still be identified as shown in Figure 3-21 when the distance is more than 1 
cm, giving evidence that electromagnetic coil coupling still exists in that distance range; 
thus longer sensing distance should be achievable if the noise floor can be reduced.
(a)       (b)                        (c) 
Figure 3-20: Photographs of the captured frequency scans showing detected impedance 
phase dip with the modified flexible-coiled sensor. (a) Sensor in proximity to reader coil. 
(b) Sensing distance = 0.5 cm. (c) Sensing distance = 0.75 cm 
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(a) (b) 
Figure 3-21: Photographs of the captured frequency scans when the sensing distance was 
1 cm. (a) Signal without sensor interaction. (b) Signal with sensor interaction. Obviously 
the phase dip is covered by the noise in this case, but slight phase change from the 
baseline signal is identifiable during experiments. 
From the need of phase-dip spectrum recovery for frequency recognition in 
further coil separation distance, a supportive data-processed external readout method has 
been developed in this work.  This method was implemented using the same 
measurement unit as previously described as it only involves post-measurement data 
processing and analysis, so that no additional efforts needed to be made on physical 
sensor and reader components.  The process scheme, as shown in Figure 3-22, is based on 
a noise reduction concept with measurement averaging [24] accompanied by frequency 
averaging procedure for better phase-dip spectra recovery.  First of all, multiple 
frequency scan samples are obtained using the measurement instrument in the 
aforementioned operation.  The samples are categorized in two groups: one where the 
reader coil is not interrogating or interacting with the sensor implant, which is defined as 
the baseline signal, and the other where the reader coil is interrogating or interacting with 
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the sensor implant, which is defined as the sensor signal.  The necessary sample data are 
captured and stored to the personal computer through a data acquisition system.  The data 
are then processed in a series of operations including the following: 1) 
baseline/background subtraction; and 2) averaging of the processed scans (i.e., time 
averaging) in common signal processing principle.  The baseline/background subtraction 
serves the purpose of eliminating substantial environmental interferences on the sensor-
reader coil interaction, and the time averaging can significantly reduce the random noise 
of the signals from the actual sensor and reader coils.  The sequence of such operations is 
interchangeable due to their linear operation nature, also resulting in the possibility of 
algorithm optimization depending on actual hardware/software constraints.  The reduced 
representative noise floor on the frequency scan after such operations can be 
mathematically represented as 
? ?sensor no sensor'? ? ?? ? ?
in Option 1 in Figure 3-22, equivalent to
sensor no sensor'? ? ?? ? ?
in Option 2 in Figure 3-22.  The processed data through Option 1 procedures, for 
example, are shown in Figure 3-23.  The measured phase noise was successfully reduced 
from the original value of ~ 0.1o to ~ 0.01o by the differentiating the signals, and further 
to ~ 0.003o after processing 20 scan samples (10 for the baseline signal and 10 for the 
sensor signal), indicating more than a 30× noise reduction so as to enhance the resultant 
sensing distance, even without signal strengthening by other modification on the sensor 
implant or the associated reader coil setup. 
(3.21)
(3.22)
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Figure 3-22: Process scheme of developed data-processed external readout method 
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Figure 3-23: Data samples through Option 1 operations for example. (a) Unprocessed 
baseline signal. (b) Unprocessed sensor signal. (c) Processed signal after baseline/ 
background subtraction. (d) Processed signal after time averaging (sample size = 20) 
After such operations, the data after baseline/background subtraction and time 
averaging operations can be investigated for detectable phase-dip frequency, as shown in 
Figure 3-23(d).  If a phase dip can be detected at a certain frequency point, the data is 
stored for the corresponding pressure measurement analysis.  If such a dip can not be 
detected, further data processing, including frequency averaging, needs to be utilized to 
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virtually increase the SNR for better phase-dip spectra recovery.  Frequency averaging is 
a common signal processing technique where adjacent samples are averaged in the 
frequency domain [25].  Similar operations based on this concept include the use of 
moving averaging in financial and economic fields.  For example, the SNR of the plot 
shown in Figure 3-23(d) can be further enhanced by appropriate frequency averaging 
with the data, as shown in Figure 3-24, for better phase dip detection.  Figure 3-25 shows 
another successful data example benefited from the frequency averaging operation.  
These examples clearly illustrate the advantages of exploiting the proposed data 
processing method.  Combining the modified implantable flexible-coiled sensor and the 
data-processed external readout method, prevailing low-noise long-range signal detection 
can be anticipated to facilitate the continuous wireless passive pressure sensing system. 
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Figure 3-24: Frequency averaging with data samples used in Figure 3-23 to illustrate the 
enhanced phase dip detection scheme. (a) Data points from Figure 3-23(d) before 
frequency averaging. (b) Smoothed curve after frequency averaging with higher SNR, 
thus more obvious phase dip over the entire frequency spectrum 
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Figure 3-25: Another data sample used to illustrate the frequency averaging operation. (a) 
Processed data before frequency averaging (sample size = 20 for time averaging). (b) 
Smoothed curve after frequency averaging with unveiled impedance phase dip 
3.5.3    Characterization results and discussions 
The modified microfabricated flexible pressure sensor has been successfully 
characterized.  The same on-bench electrical testing configuration was utilized for 
electrical characterization of the device, with the experimental results listed in Table 3-3, 
for comparison with the previous sensor prototype in fixed coil design.  Smaller electrical 
inductance, capacitance, and resistance resulted in a higher resonant frequency and higher 
quality factor of such paradigm.  A modified pressure control configuration, as shown in 
Figure 3-26, was utilized for wireless pressure sensing demonstration.  The device was 
placed inside the customized chamber connected to a pressurization setup where a 
commercial off-chip pressure regulator and a pressure gauge were used to provide 0.5 
mmHg tuning resolution.  Accurate environmental pressure variations could thus be 
created for the device (?P = Poutside sensor – Pinside sensor) with this pressure-control setup. 
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Table 3-3: Measured electrical parameters of the flexible-coiled pressure sensor 
Parameters Values 
Inductance 57 nH 
Capacitance 3.6 pF 
Resistance at resonance 4.2 ?
Resonant frequency ~ 350 MHz 
Quality factor ~ 30 
Figure 3-26: Schematic of on-bench pressure testing setup for characterization of the 
modified flexible-coiled sensor 
Although the pressure sensitivity was expected to be small due to the use of a 
smaller and less flexible circular parylene diaphragm, it was compensated by the high 
resonant frequency, resulting in a reasonable pressure responsivity for detection of phase-
dip shift with respect to environmental pressure variations.  Measured phase-dip curves 
and a sensitivity characterization curve were obtained, as shown in Figures 3-27 and 3-28, 
to characterize the wireless pressure sensing behavior.  A similar relation to (3.17) was 
used in the analysis with different sign convention due to a different pressurization 
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situation.  It was also observed that the aforementioned volume change effect from the 
encapsulated air/gas reference was non-negligible in this case.  As shown in Figure 3-29, 
the ideal pressure sensitivity was designed to be 985 ppm/mmHg, while in measurements 
only 455 ppm/mmHg sensitivity was obtained when the sealed cavity volume was 500 
?m × 2,000 ?m × 250 ?m (width × length × height).  By designing different geometry on 
the non-electronic sealing piece to double the sealed cavity volume (500 ?m × 2,000 ?m
× 500 ?m) in the final packaged device, the pressure sensitivity and responsivity was 
experimentally characterized to be 695 ppm/mmHg and 243 kHz/mmHg, approximately 
1.52× enhancement over the original values and closer to the ideal values.  These results 
were in good agreement with expectations after incorporating the ideal gas law, and 
showed the possibility of altering/optimizing the design parameters depending on actual 
application specifications. 
Figure 3-27: Overlay plot of the measured phase-dip curves of the modified sensor in on-
bench wireless pressure sensing. ?P = Poutside sensor – Pinside sensor .
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Figure 3-28: On-bench pressure testing result of the modified sensor 
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Figure 3-29: Characterization of volume change effect of the encapsulated air 
Next, the data-processed readout method was incorporated for sensing distance 
studies of such a wireless system.  For demonstration purposes, devices with different e-
beam evaporated gold thicknesses (3 ?m/0.5??m and 6 ?m/1 ?m for first and second 
metal layer structures, respectively) were prepared.  The doubled metal thickness resulted 
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in approximately 1.5× Qs enhancement (from ~ 30 to ~ 45).  This enhancement was 
primarily limited by the high-frequency skin depth effect from the inductor wire 
resistance at the operating frequency.  Also it is worth noting that the metal line thickness 
could be further increased by depositing thicker metal through current evaporation 
methods or an electroplating alternative, or by stacking in a special post-microfabrication 
technique [26] to further reduce the series resistance of the inductor and enhance the 
overall quality factor.  The necessary number of samples for averaging operations 
depends on the final frequency measurement resolution needed for ultimate pressure 
sensing.  The frequency noise (i.e., frequency fluctuation) in measurements needs to be 
lower than the resultant frequency shift from environmental pressure variation for reliable 
pressure sensing accuracy.  As previously stated, the pressure sensitivity of the modified 
flexible-coiled sensor was characterized to be approximately 455 ppm/mmHg, which 
meant the allowed frequency fluctuation must be lower to achieve 1 mmHg pressure-
sensing accuracy.  With this information, experiments were designed to verify the sample 
size effect on SNR and frequency fluctuation.  Using a Qs ~ 45 sensor with a 4-mm-
diameter on-sensor coil interrogated by a 15-mm-diameter hand-wound reader coil at 2 
cm separation distance, the results are shown in Figure 3-30(a) with the SNR defined as 
max
noise
SNR ?
?
??
?
where ??max is the maximum?impedance phase dip throughout the frequency scan, and 
??noise is the noise from the measurement system.  More than 80 measurement samples 
had to be collected in order to justify SNR > 10 and the associated frequency shift 
resolution less than 400 ppm.  Fewer samples could be collected but the overall pressure 
, (3.23)
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accuracy would be reduced.  On the other hand, more samples could be collected but the 
processing capacity and time would need to be considered.  Given this result the required 
pressure accuracy in specific applications and the physical noise in the measurement 
system determine the size of data to be collected and analyzed.  Figure 3-30(b) shows that 
the achieved ??noise was lower than 0.0015o by processing more than 80 samples (40 for 
sensor signal and 40 for baseline signal) and approaching the limit (~ 0.001o) when more 
than 200 samples were collected.  This limit resulted from the noise sources which could 
not be cancelled or suppressed, so fundamental reader unit modifications—including the 
use of a low noise amplifier (LNA) or other low-noise electronic techniques, as 
introduced at the end of this section—would be necessary to fundamentally reduce the 
system noise, and thus achieve higher SNR and longer range sensing. 
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Figure 3-30: Sample size effect on frequency measurements. (a) Obtained SNR and 
frequency shift resolution. (b) Obtained ??noise with the exponential fit illustrating the 
reduction limit of using the data-processing readout method. Half of the samples were 
collected from sensor signal and the other half were from the baseline/background signal. 
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Sensing distance enabled by the aforementioned flexible-coiled sensor and the 
data-processed external readout method was studied.  The criterion of determining 
maximum sensing distance was set to be SNR > 10 given the minimal ??noise ~ 0.001o so 
that the phase-dip frequency measurements were sufficiently accurate for analyzing 1 
mmHg pressure difference.  The maximum sensing distance was therefore characterized 
to be 2 cm and 2.5 cm for Qs ~ 30 (3 ?m/0.5??m metal structures) and Qs ~ 45 (6 
?m/1??m metal structures) sensors, respectively.  Experiments using a Qs ~ 45 sensor 
with approximately 4-mm-diameter on-sensor coil interrogated by hand-wound reader 
coils in different sizes were conducted to further study the relation between coil 
separation distance and associated electrical performance.  Figure 3-31 clearly shows that 
the phase dip and the derived coupling coefficient from (3.4) decreases as the coil 
separation increases, with an empirical relation equivalent to that found in [24] as 
1
3
    when  
    when  
?
?
?
?
? ???
?
??
p
p
k z z r
k z z r
where z is the coil separation distance and rp is the reader coil radius.  The obtained phase 
dip-distance product analogous to gain-bandwidth product was higher for larger reader 
coils.  Both the near-field and far-field coil coupling situations were well described by 
(3.24), and were in good agreements with theoretical expectations that are derived from 
[14, 24, 27–29]. With these findings, the ultimate reader coil can be properly designed 
and realized as part of the glasses-type reader shown in Figure 3-2, incorporating the 
necessary glasses-to-iris distance (1.5–2 cm) in practical wireless sensing.  As a result, 
the demonstration using the sensor prototype verifies the feasibility of modifying sensor 
parameters to increase the sensing distance for the required IOP monitoring specifications. 
(3.24),
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Figure 3-31: Sensing distance study using Qs ~ 45 sensor with approximately 4-mm-
diameter on-sensor coil. (a) Measured maximum phase dip plot. (b) Derived coupling 
coefficient plot using (3.4) 
 On-bench experimental studies also indicated that the sensor-reader coil coupling 
is substantially influenced by the medium in which the sensor is placed.  As shown in 
Figure 3-32, the phase-dip frequency was varied from 350 MHz in air to approximately 
275 MHz in liquid (water and 0.9% saline) environments, approximately 29% difference.  
This frequency shift is due to the higher permittivity of water-based solutions (dielectric 
constant ?r ~ 80 at 20°C) than that of air (?r ~ 1).  It causes increased electrical field 
concentration on the medium, and so virtually increases the total equivalent capacitance 
and decreases the resultant phase-dip frequency measured from the external reader.  
Furthermore, for lossy medium such as saline, the permittivity can be written in the 
complex form as [29–31] 
j? ? ?? ??? ? (3.25),
noise floor 
SNR < 10 
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with the loss tangent defined as the ratio ? ??? ?  a measure of the power loss in the 
medium.  Different loss tangent values of water (~ 0) and 0.9% saline (~ 0.2 [11, 31]) 
reflect their different lossy extent as media degrading the electromagnetic coupling of the 
coils.  As a result, the measured quality factor was around the same value when the 
sensor was in water as compared with air, while it dropped to ~ 6 when the sensor was in 
saline.  The incorporated sensing distances in water and saline were characterized as 2.5 
cm and 1.5 cm, respectively.  Solutions to overcoming the decreased sensing distance in 
saline that has similar composition and properties to the aqueous humor need to be 
developed, despite the fact that 1.5 cm could be sufficient for practical IOP monitoring.  
Future works will be investigations on reducing the lossy medium effect using the 
methods including, but not limited to: 1) strengthening electrical isolation between sensor 
structures and the environment [11]; and 2) increasing operation/phase-dip frequency to 
minimize ionic relaxation in response to electromagnetic waves [31].  In addition, the 
device pressure sensitivity was found invariant to different surrounding media. 
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Figure 3-32: Interaction effect in different wave-transmission media. The measured Qs’
were ~ 45 in air, ~ 45 in water, and ~ 6 in 0.9% saline using the flexible-coiled sensors. 
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 Because the operation principle of such a sensor involves encapsulated air/gas 
reference, the corresponding phase-dip frequency drift due to possible changes of 
reference needs to be studied as well to verify the sensing feasibility of the sensors.  The 
temperature sensitivity was characterized on-bench as approximately 1064 ppm/°C, in 
good agreement with design expectations, considering a closed-system air/gas expansion 
effect based on the ideal gas law.  The overall pressure accuracy obtained from this 
sensor was therefore approximately 2.5 mmHg, incorporating ±1°C temperature 
fluctuation in the implantation environment (i.e., inside the human body).  Other than 
using temperature compensation techniques, the air/gas reference inside the sensor could 
be sealed either under low pressure (ultimately in vacuum, as in absolute pressure sensors 
[21]) or at high temperature so as to directly reduce the pressure-temperature correlation 
effect.  The encapsulated air/gas could also be replaced by liquids to eliminate such effect.  
After implementing these concepts in device packaging, the pressure sensing accuracy 
could potentially be improved to 1 mmHg as promised for practical IOP monitoring.  
Sensor soak tests showed that the phase-dip frequency drift was less than 500 ppm, 
equivalent to the result by 1 mmHg pressure variation, when the sensor was submerged in 
saline more than 100 hr at both 25°C and 37°C, confirming the effectiveness of parylene-
metal-parylene isolation to liquid/gas permeation and absorption that could affect the 
pressure reference cavity and other sensor structures [11].  Table 3-4 summarizes 
important characteristics of the microfabricated flexible-coiled wireless pressure sensor 
in this work.  With the improvements shown here along the way after the developments 
of the first version of the device, future works on the engineering side will be focused on 
enhancing pressure accuracy, sensing distance, and device reliability. 
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Table 3-4: Measured characteristics of the flexible-coiled pressure sensor 
Parameters Values 
Planar dimensions (normal) 4 mm diameter (folded) 4 mm × 1.5 mm
Resonant frequency ~ 350 MHz 
Quality factor ~ 30/~ 45* (in air) 
Sensing distance 2 cm/2.5 cm* (in air) 
Pressure sensitivity 455 ppm/mmHg†
Pressure responsivity 160 kHz/mmHg†
Temperature sensitivity 1064 ppm/°C 
Resonant frequency drift in 
saline environment 
< 500 ppm after 100 hr 
(at 25°C and 37°C) 
Projected pressure accuracy in 
practical IOP monitoring 2.5 mmHg
‡
*Altered by different inductor wire thickness 
† Influenced by volume change effect of the encapsulated air 
‡ Could be improved by modifying encapsulated air conditions 
In surgical aspect, a flexible ophthalmic iris retractor (Alcon/Grieshaber AG, 
Schaffhausen, Switzerland) was modified on bench using a razor blade, and attached to 
the non-electronic sealing piece using epoxy (as shown in Figure 3-33) to serve as the 
tissue anchor for suture-less implant fixation.  This surgical attachment and the 
microfabricated sensor were assembled as the final packaged device.  After being 
introduced to the anterior chamber, the tapered feature at the end of the retractor hook 
penetrates the iris and provides sufficient anchoring to the device in the implant location.  
This anchoring process is reversible if the implant needs to be removed from the eye. 
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Figure 3-33: Representative iris anchor assembly result (side view) 
Figure 3-34 shows the implant location in the intraocular environment after 
surgery using a live rabbit model.  The implant was secured on the iris in the eye with the 
modified retractor-assembled anchor attachment.  Before implantation the packaged 
device was conformally coated by a thin parylene layer to ensure its biocompatibility in 
the intraocular environment.  The entire surgery was completed within 15 min because of 
its minimally invasive (< 2 mm incision) nature, which minimizes surgical and post-
operative complications.  In addition, facilitated by the compatible surgical procedures, 
this implant location has a tremendous advantage in aligning sensor and reader coils so 
that possible loss of signal strength through coil misalignment can be reduced.  Follow-up 
study results (including fluorescin angiography and fundus photograph as shown in 
Figure 3-35) confirmed that no device dislocation or post-operative complications, 
including inflammatory response or tissue encapsulation/fibrosis, were found over 3 
months, verifying the surgical/biological feasibility of using such implant paradigm with 
appropriate anchoring mechanism in the intraocular environment. 
Non-electronic sealing piece
Modified iris retractor 200 ?m
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Figure 3-34: Implanted flexible-coiled pressure sensor in the intraocular environment of 
rabbit eye model. The arrow indicates the implant as observed through the cornea. 
         
(a)                        (b) 
Figure 3-35: Follow-up study results of in vivo device testing using rabbit model to verify 
biocompatibility of the modified flexible-coiled implant. (a) Fluorescein angiogram 
showing no noticeable blood vessel leakage at the implantation site one week after 
surgery. (b) Fundus photograph showing no device dislocation or post-operative 
complications appeared in the intraocular environment. 
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 In order to demonstrate the in vivo wireless pressure sensing feasibility of such a 
flexible-coiled sensor paradigm, acute animal testing using rabbit eye models was 
conducted with an experimental setup as shown in Figure 3-36, similar to that previously 
shown in Figure 3-13 except using a live rabbit and placing the sensor on the iris as in 
Figure 3-34, with minimally invasive surgical procedures.  The obtained phase-dip curves 
were much clearer and more appropriate for pressure analysis as compared with those in 
Figure 3-14, attributable to higher SNR using the modified sensor and the developed 
data-processed external readout method.  Although limited by the pressure control and 
monitoring scheme in surgical protocols at the moment of experiment such that no 
pressure measurement analysis could be performed, the shifted phase-dip curves 
correlated to a qualitatively increased IOP in the model, and markedly verified the 
pressure-sensing feasibility using the developed implant in the intraocular environment. 
          
(a)                         (b) 
Figure 3-36: Acute in vivo device testing using rabbit model. (a) Photograph of 
experimental setup. (b) Overlay plot of the measured phase-dip curves in wireless 
intraocular pressure sensing. 
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 Given the results in the acute in vivo testing, an improved and more quantitative 
ex vivo study was completed using an enucleated porcine eye as the animal model to 
characterize the pressure response of the sensor in the simulated intraocular environment.  
An intraocular manometer was used with the infusion-based pressurization setup in this 
experiment to obtain precise IOP measurements as compared with the readouts from the 
sensor.  The results shown in Figure 3-37 were analyzed and confirmed in good 
agreement with the on-bench results shown in Figure 3-27, indicating that the physical 
pressure response of the developed sensor was consistent when situated in different 
environments, regardless the different electrical readouts due to the medium effect.  
Extensive animal studies, including acute and chronic tests, are still underway in order to 
completely characterize the in vivo performance of the flexible-coiled wireless pressure 
sensor paradigm.  Advanced surgical protocols and tools suitable for such an implant 
paradigm will also be investigated to better meet the future requirements in practice. 
200 220 240 260 280 300
-0.6
-0.5
-0.4
-0.3
-0.2
-0.1
Scanning Frequency (MHz)Im
pe
da
nc
e
 P
ha
se
 D
iff
er
en
ce
 (d
e
g)
 IOP = 35 mmHg
 IOP = 47 mmHg
 IOP = 55 mmHg
Figure 3-37: Acute ex vivo device testing using enucleated porcine eye model 
Future work will also be focused on reader optimization and actual 
implementation.  Development of a low-noise measurement system will be the first 
IOP ?
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keystone.  As described previously, besides improvements from using the developed 
data-processing-based readout method from a software perspective, low-noise circuitry 
and techniques from a hardware perspective should be included to electronically reduce 
the measurement noise and enhance the SNR in phase-dip frequency detection [9, 24].  
Other readout methods have also been explored in different research groups [32–34] with 
the aim of long-range telemetric sensing, and are valuable for comparison to the 
configuration proposed in this work.  For example, derived from the grid-dip detection 
technique, a variable capacitor or a voltage-controlled oscillator (VCO) can be placed on 
the readout circuit to amplify the sensor response on the principle of minimizing the 
imaginary term of (3.3) at resonance.  In this way, the sensing resolution as well as the 
corresponding detectable distance can be greatly improved.  Other physical examples 
include the use of two coils on the reader side [32] to increase the electromagnetic 
detection zone for longer sensing distance.  Moreover, in cases where either the sensor-
reader coil coupling or quality factor of the sensor is substantial enough to influence the 
frequency shift resolution based on (3.14), some compensation method would be required 
as part of the final telemetric system.  For example, a distance-compensated technique 
[35] can be applied under this concept to obtain correct frequency values regardless of 
possible out-of-plane positional variation between the glasses (reader) and the iris 
(sensor), which is valuable for further study.  These developed techniques involving 
additional electrical components or microelectronics implementation might be 
incorporated into the current readout method and will be extensively studied in the future.  
After successful reader development, this wireless implant-based pressure sensing 
approach will be complete for practical continuous IOP monitoring and glaucoma study. 
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3.6 Summary 
An implantable unpowered micromechanical parylene-based pressure sensor has 
been successfully developed in this chapter as part of a new implant paradigm using 
electrical sensing methodology to realize continuous IOP monitoring.  Complete design, 
fabrication, and characterization of the microsensors are described.  Sensors with 
electrical resonant circuitry in pressure-sensitive variable capacitor and variable 
capacitor/inductor designs were implemented to facilitate wireless pressure sensing 
through an inductive coupling link with an external reader.  Low-temperature multi-layer 
polymer/metal micromachining technology enables integrated sensor components 
fabricated on a monolithic substrate without the need for a multi-wafer bonding process.  
Sensors with implantable dimensions as well as appropriate surgical features were 
microfabricated in a suitable form factor for intraocular implantation.  Engineering and 
surgical/biological performance of the sensors were characterized in on-bench, ex vivo,
and in vivo experiments, and shown to be in good agreement with design parameters.  
With the successful proof of concept and the future implementation of the proposed 
sensor/reader improvement strategies, this new IOP sensing paradigm has great potential 
for fulfilling continuous, unpowered, real-time, reliable, and convenient IOP monitoring 
in glaucoma patients. 
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CHAPTER 4
IMPLANTABLE PARYLENE-BASED 
INTRAOCULAR PRESSURE SENSORS 
WITH OPTICAL READOUTS 
4.1 Overview 
This chapter presents an implantable, unpowered, parylene-based wireless MEMS 
pressure sensor for IOP monitoring in an optical sensing paradigm to investigate its 
feasibility and possibility other than the electrical sensing paradigm described in Chapter 
3.  From in situ mechanical deformation of the compliant spiral-tube structures, this 
sensor can register pressure variations without electrical or powered signal transduction.  
Micromachined high-aspect-ratio polymeric hollow tubes are implemented to obtain 
high-sensitivity pressure responses.  An integrated device packaging method has been 
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developed to enable minimally invasive suture-less needle-based implantation of the 
device.  In vitro and ex vivo device characterizations have successfully demonstrated 1 
mmHg resolution of the pressure responses, along with verifications of biocompatibility 
and fixation functionality of the implant in the intraocular environment.  Facilitated by 
the implantation scheme, the pressure response of the implant can be directly and 
optically observed from outside the eye under visible light, with the goal of realizing 
convenient, direct, and reliable IOP monitoring in glaucoma patients. 
4.2 Implant Design 
4.2.1    Sensing scheme 
 This implant facilitates an optical pressure-sensing technology by using a 
micromechanical sensor with observable deformation to environmental pressure 
variations.  When the sensor is implanted on the iris of the eye, its in situ mechanical 
pressure response corresponding to the IOP variation can be observed with an optical 
reader—as straightforward as a camera, a microscope, or a stereoscope—from outside the 
eye through the transparent cornea without the need for electrical circuitry or external 
powered signal transduction.  The device is fabricated in a small form factor suitable for 
minimally invasive suture-less implantation.  Similarly to telemetric sensing, this optical 
methodology has the potential of enabling a patient to read his/her own IOP (e.g., using 
his/her one eye to observe the other where the sensor is implanted through a special 
binocular reader) instead of clinical visits, resulting in more practical and convenient 
continuous IOP tracking.  Sensing distance and pressure readout resolution depend on the 
depth of focus and optical magnification from the external reader to the sensor implant. 
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4.2.2    Sensor design 
The IOP sensing element, as shown in Figure 4-1, is a high-aspect-ratio compliant 
structure inspired by a Bourdon tube, a free-standing curved hollow tube [1, 2].  It has a 
systematic, well-defined pressure response on its mechanical conformation.  The tube 
deforms to respond to a bending moment generated by a pressure difference applied 
between the pressure encapsulated in the tube/channel and the ambient pressure.  The 
deformation, which can be visualized by movement of the pointing tip at the free end of 
the tube, is linearly related to this pressure difference.  Therefore, the corresponding 
environmental pressure outside the tube can be measured, given that the pressure inside 
the tube is set at a predetermined constant.  Because of the visible tube deformation after 
implantation, direct IOP measurements can be obtained through optical observation.  
Variation in IOP can occur due to reasons such as treatment of underlying disease, 
diurnal rhythm, and atmospheric pressure change.  All of these changes would be 
accurately detected by the sensor.  Different geometric designs can be used to amplify the 
tube deformation as well as modify its in-plane deformation trajectories.  Table 4-1 gives 
possible layouts of the IOP sensor design. Improved from the basic Bourdon tube design, 
an Archimedean spiral layout can be utilized to increase the angular rotation at the end 
pointing tip as well as a long-armed spiral tube used to further enhance the lateral 
movement of the end arm.  These tube geometries can both enlarge the pressure 
sensitivity and optimize the device dimensions for suture-less clinical implantation using 
small outer-diameter needles.  Moreover, the minimized out-of-plane deformation using 
these symmetric tube designs leads to more accurate pressure readouts in optical 
observation of the sensor implant. 
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Figure 4-1: Concept of the micromechanical IOP sensor for optical sensing. Different 
directions of tube rotation result from different pressure conditions across the tube. 
Table 4-1: Geometric designs of compliant structures for the IOP sensor 
Curved tube 
(Basic Bourdon tube)
Spiral tube 
(Angular deformation)
Long-armed tube 
(Amplified rotation)
As the main component of the IOP sensor, the thin-walled hollow tube needs to 
be flexible for more sensitive pressure responses and higher sensing resolution.  
Conceptually, higher-aspect-ratio tubes in a specific shape (e.g., elliptical or rectangular 
 High-aspect-ratio 
 hollow channel 
outside pressure < inside pressure
outside pressure > inside pressure
Poutside > Pinside
Poutside < Pinside
Poutside > Pinside
Poutside < Pinside
Poutside > Pinside
Poutside < Pinside
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cross-section) are necessary to obtain larger in-plane deformations and stronger out-of-
plane resistance to environmental interference.  Parylene C is selected as the structural 
material for the tube because of its desirable properties, including mechanical flexibility, 
chemical inertness, and biocompatibility, as described in the Appendix.  More 
importantly, its pinhole-free thin-film conformal coating ability enables fabrication of 
high-aspect-ratio hollow tubes in single material layer.  These factors support utilization 
of parylene for such flexible and implantable biomedical microdevice. 
4.2.3    Device packaging 
Because the pressure sensor is designed to be implanted inside the eye for direct 
IOP measurement, packaging is necessary to ensure that the IOP sensor is fully functional 
after implantation.  In order to avoid handling and alignment issues during assembly, a 
wafer-level integrated device packaging method has been developed.  By implementing 
micromachining technology, a fully packaged device comprising the following 
components can be fabricated on a monolithic substrate as shown in Figure 4-2: 1) a 
sensor platform to support the IOP sensor; 2) bottom posts with an end “anchoring feet” 
design to realize suture-less anchoring of the implant on the iris [3]; and 3) a perforated 
flexible parylene membrane to protect the sensor from damage during implantation.  
With these features, a packaged device can be implanted on the iris so that faithful IOP 
readouts from the sensor are observable from outside the eye through the cornea and the 
protective parylene membrane.  The resulting implant fixation method also obviates the 
use of sutures while additionally favoring a minimally invasive implantation scheme that 
curtails complications during and after surgery. 
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Figure 4-2: Schematics of fully packaged implantable device (not to scale) 
4.3 Device Fabrication 
Two types of IOP sensors, high-sensitivity and needle-implantable, were 
microfabricated.  The high-sensitivity sensor is a simplified version that includes only the 
parylene tube, while the needle-implantable sensor has a smaller form factor and has all 
necessary components for implantation: The parylene tube, the top protective membrane, 
and the bottom tissue anchoring structures.  All sensors were microfabricated on a 
monolithic substrate to accomplish integrated device packaging.  Figure 4-3 illustrates the 
fabrication process of the needle-implantable sensors.  The process began with growing a 
0.75-μm-thick wet oxide on a 500-μm-thick double-side-polished silicon wafer.  After 
patterning the backside oxide using buffered hydrofluoric acid and photoresist as a mask, 
backside two-step DRIE in a PlasmaTherm™ SLR system was performed to define the 
backside access holes, as well as 200-μm-high feet anchors and trench boundaries of the 
sensor platform.  A novel embedded channel fabrication technology was then employed 
to create the high-aspect-ratio quasi-rectangular parylene channels [4].  With frontside 
Protective membrane 
Anchoring feet 
IOP sensor 
Platform
Bottom ViewTop View
 93  
oxide patterning, two-step complementary plasma-based dry etching, and an 8-μm-thick 
parylene C deposition, 180-μm-high, 16.5-μm-wide thin-walled embedded channels with 
5-μm-thick parylene walls were successfully fabricated.  Channels with an internal 
channel aspect-ratio of approximately 26 with a quasi-rectangular profile, where the 
sidewall angle ~ 90°±1°, were obtained to achieve large mechanical responses.  The 
backside holes located at the center of the tubes were also connected to the inside of the 
parylene channels after the frontside trench etching.  These holes would be sealed after 
device fabrication to encapsulate air at a constant pressure inside the tubes.  Oxygen 
plasma etching with a photoresist etch mask was performed to separate the embedded 
parylene channels into tube patterns with various geometric designs (spiral tube and long-
armed tube described above).  Subsequent to removal of the remaining frontside oxide, a 
sacrificial photoresist layer was spin-coated and the second parylene C layer was 
deposited and patterned to construct a 10-μm-thick perforated parylene membrane caging 
the channels from 20 ?m above.  Finally, the photoresist was stripped with acetone and 
the parylene channels were released using an isotropic gas-phase XeF2 silicon etch in a 
customized system.  Using the same through-wafer technique, the entire microdevice was 
separated from the wafer substrate after XeF2 etching without dicing while the main body 
of the device remained intact due to protection from the parylene-filled trenches depicted 
in Figure 4-3.  A thin layer of parylene could be further coated on the released device to 
promote its biocompatibility. 
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Figure 4-3: Fabrication process flow of the needle-implantable sensors as example. The 
arrow indicates the location of sealing to parylene tube. 
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Figure 4-4 shows the high-sensitivity IOP sensors micromachined using only the 
parylene tube fabrication process.  Sensors of both the spiral-tube and long-armed-tube 
design were successfully fabricated.  Note that the indicators surrounding the sensors 
were fabricated at the same time to accurately determine the position of the end pointing 
tip.  Micromachined integrated packaging components for the needle-implantable IOP 
sensors before the final XeF2 device release are shown in Figure 4-5.  The embedded IOP 
sensors are clearly observable through the top perforated protective membranes due to the 
optical transparency of parylene.  An excessively long leverage arm should be avoided as 
it has a substantial mechanical resistance and thus affects the rotational behavior of the 
spiral tube.  Instead, a pair of long-armed-tube sensors could be placed in the same 
platform to effectively double the pressure-related movement by observing the distance 
between the pointing tips.  This “rotation-tip” readout amplification method is promising, 
but requires delicate calibration of the residual stress in the parylene structures for good 
alignment of the pointing tips after tube release [5–7].  Compared with the spiral-tube 
sensors, the long-armed-tube sensors were better suited for fabrication in a form factor 
that can be accommodated inside a 19-gauge needle, as shown in Figure 4-6, while still 
achieving a reasonable pressure response. 
Figure 4-4: Microfabricated high-sensitivity parylene-based IOP sensors in spiral-tube 
(left) and long-armed-tube (right) designs 
200 ?m200 ?m
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Figure 4-5: Integrated packaging components of the needle-implantable parylene-based 
IOP sensors. (a) Micrograph of the parylene tube in long-armed-tube design under the 
perforated parylene membrane before final device release (top view). (b) Example of the 
backside tissue anchor with its top (left) and side (right; 200 μm in height) views 
(a)               (b) 
Figure 4-6: Microfabricated needle-implantable parylene-based IOP sensors. (a) Released 
devices. (b) A device implant situated inside a 19-gauge hypodermic needle 
The important physical dimensions of the microfabricated IOP sensors 
characterized in the following sections are listed in Table 4-2. 
(a)
(b)
100 ?m
100 ?m
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Table 4-2: Design metrics of the fabricated micromechanical IOP sensors
High-sensitivity sensors
(large form factor) 
Needle-implantable 
sensors (small form factor)
Tube design Spiral tube Long-armed tube Long-armed tube 
Overall size 2 × 2 × 0.5 mm3 4 × 2 × 0.5 mm3 3 × 0.6 × 0.5 mm3
Spiral diameter ~ 1,100 μm ~ 1,100 μm ~ 400 μm 
Spiral turns 15 15 8 
Pointing tip length 100 μm 1,500 μm 750 μm 
Indicator separation 5° 80 μm 20 μm 
4.4 Characterization Results and Discussions 
4.4.1 In vitro pressure sensing test 
The microfabricated parylene-based pressure sensors were first tested on-bench to 
characterize their in vitro pressure responses.  All parylene tubes were sealed by applying 
epoxy over the backside access holes under atmospheric pressure (1 atm) at room 
temperature; this served as the gauge reference pressure.  A customized pressure 
regulation setup (as shown in Figure 4-7) was used to vary the environmental pressure 
surrounding the sensors, in which a off-chip pressure regulator and a pressure gauge were 
used to control the pressurization with 0.5 mmHg tuning resolution.  Structural 
deformation of the sensors with respect to different positive pressures was measured 
using a stereoscope and compared with numerical readouts from a pressure gauge.  
Because the parylene tube structures are strengthened by their high-aspect-ratio shape, 
the sensors were not affected by stiction on their underside to the platform and were 
completely functional in both air and liquid media.  Prior to immersion and operation in 
liquid, however, the sensors need to experience appropriate surface treatments such as 
short oxygen plasma roughening in order to reduce the severity of bubble formation on 
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parylene surfaces [7], which can result in device failure.  The pressure testing of the 
sensors was conducted in water to mimic the intraocular environment.  For the high-
sensitivity sensors, the testing results shown in Figure 4-8 indicate that their pressure 
sensitivity was 0.47°/mmHg in rotational displacement with the spiral-tube design and 
11.23 μm/mmHg in lateral displacement with the long-armed-tube design, both showing 
a continuous pressure response (i.e., continuous pointing tip rotation) with high linearity.  
These data further verify that different geometric tube layouts result in different 
trajectories of tube deformation.  The pressure sensing resolution was approximately 3.56 
mmHg obtained with the long-armed-tube sensors, which falls in the range of interest for 
IOP measurements.  This resolution was determined by the confidence of observation of 
tip movement through half the distance between 80-μm-spaced indicators.  Therefore, 
even without redesigning the parylene tube structure, higher pressure resolution could be 
achieved using indicators with a smaller separation and optical readers with higher 
magnification.  This fact leaves room to further optimize the micromechanical pressure 
sensor.  The needle-implantable sensors with long-armed-tube design also demonstrated a 
3.21 μm/mmHg pressure sensitivity in lateral displacement, as shown in Figure 4-9. 
Figure 4-7: Schematic of on-bench pressure testing setup for device characterization 
Release 
Valve
Pressure Gauge
Valve
FilterGas Cylinder
Chamber
0.01 psi
Regulator
Stereoscope
+ CCD Camera 
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(a)
(b)
Figure 4-8: In vitro pressure response of the high-sensitivity IOP sensors in water. (a) 
Spiral-tube design. (b) Long-armed tube design. The figures include snapshots of tip 
movements before and after pressurization and associated measurement data. 
(a)
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Figure 4-9: In vitro pressure response of the needle-implantable IOP sensors in water. (a) 
Snapshots of tip movement before and after pressurization. (b) Measurement data 
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4.4.2 In vivo anchoring test 
The micromachined tissue anchors have been studied to evaluate their in vivo
efficacy under normal conditions in a rabbit eye model.  All devices were sterilized using 
ethylene oxide gas prior to their implantation through a small angled razor blade incision 
at the cornea of the rabbit eyes.  The dummy silicon substrate with three anchoring feet 
(all components coated with approximately 1.5 ?m of parylene C) were implanted using 
forceps and gently depressed from above to embed the anchors in the iris.  After 
retraction of the forceps, no additional steps such as suturing procedures were necessary 
to close the corneal incision.  The entire implantation was completed in an extremely 
short time period, typically less than 5 minutes.  As observed in Figure 4-10, after 1 
month of surgery, there was no device movement detectable in either of the rabbits 
implanted with the crossed anchor design illustrated in Figure 4-5.  Furthermore, the 
follow-up fluorescein angiography over the month showed only very minimal leakage of 
blood in the iris, indicating that the anchors caused only minor trauma to the iris during 
implantation and this leakage diminished over time. 
Figure 4-10: In vivo anchoring test with fundus photograph (left) and fluorescein 
angiogram (right) taken after 1 month of study. The arrows indicate the implant location. 
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4.4.3 Ex vivo pressure sensing test 
Implantation testing has been conducted in several enucleated porcine eyes to 
characterize the expected in vivo performance of the IOP sensors.  For the high-
sensitivity sensors, an angled blade incision and corneal suturing were performed to 
implant the devices due to their large physical dimensions.  Test results demonstrate that 
both the spiral-tube and long-armed-tube designs successfully registered IOP variations 
in the intraocular environment under external observation with a surgical microscope 
with approximately 2.4× magnification.  Repeatable pressure responses of the sensors 
were confirmed by applying cyclic pressure variations.  Figure 4-11 shows that a real-
time 8.72 μm/mmHg sensitivity was obtained in the long-armed-tube sensors, proving the 
microfabricated IOP sensors can achieve pressure sensing at the mmHg level in the 
intraocular environment.  The needle-implantable sensors, in spite of their minimally 
observable pressure responses due to low optical magnification of the scope, were 
successfully implanted using a 19-gauge needle shown in Figure 4-12. 
Figure 4-11: Ex vivo pressure response of the high-sensitivity long-armed-tube IOP 
sensor. The arrow indicates the position of the end pointing tip which changes with 
respect to the pressure variations in the intraocular environment. 
High IOP (88 mmHg) Low IOP (29 mmHg)
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(a)               (b) 
Figure 4-12: Ex vivo characterization of the needle-implantable IOP sensor. (a) Device 
implantation through a needle incision. (b) Device implanted inside the eye. The tissue 
anchors mechanically secure the device on the iris in the intraocular environment. 
4.4.4 In vivo implantation test 
As another proof-of-concept demonstration, the needle-implantable pressure 
sensors were implanted in rabbit eyes and examined over time to evaluate their 
biostability.  Over the 2-week follow-up period, one device still maintained its position as 
shown in Figure 4-13 while another dislodged, possibly due to the large number of 
anchors in the middle of the device preventing good contact of the ends of the device 
with the iris.  Other than that, after 2 weeks, fluorescein angiography (as shown in Figure 
4-13) confirmed only minimal leakage of blood around the device, again indicating only 
minor trauma to the iris.  Devices that were completely coated in parylene showed almost 
no tissue encapsulation as compared to those with exposed silicon surfaces, which 
produced a discernable tissue response.  Future work will center on determining the 
optimal anchor number and geometry for more reliable device implantation in the 
intraocular environment, and on increasing pressure sensitivity of the implant in a smaller 
form factor for more practical IOP monitoring. 
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(a)                   (b) 
Figure 4-13: In vivo animal study using rabbit eyes with functional needle-implantable 
IOP sensor. (a) One week after implantation with no device dislocation. (b) Two weeks 
after implantation with fluorescein angiogram showing minimal blood leakage 
4.4.5   Temperature effect characterization 
Because the device is in gauge pressure sensing configuration where encapsulated 
air is involved as the pressure reference, the performance of such spiral-tube sensor 
would have temperature effect [8], as shown in Figure 4-14.  This behavior needs to be 
studied as the temperature in the intraocular environment can vary with human body 
temperature (±1°C in normal maximum).  When the air inside the tube is sealed, its 
pressure changes as a function of temperature based on the ideal gas law: 
PV nRT?
where P and V are the pressure and volume in the closed system, n is the number of 
moles of gas particles, R is the universal gas contant, and T is the environmental 
temperature.  Obviously, this effect explains that a temperature change inside the tube 
can lead to a pressure difference across the tube in a fixed air volume, so that the tube 
deformation is also correlated with environmental temperature variation. 
(4.1),
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Figure 4-14: Illustration of temperature effect on the IOP sensor. Directions of tube 
rotation by temperature variation are correlated to the pressure difference across the tube. 
 In order to characterize this temperature effect, a test structure having a 40-mm-
long, 17-turn spiral tube out of a 190-?m-deep, 12-?m-wide, 3-?m-thick-walled high-
aspect-ratio (internal channel height/channel width greater than 30) parylene channel was 
fabricated, as shown in Figure 4-15.  The parylene spiral tube was sealed by applying 
epoxy on the backside access hole under 1 atm at 20°C to provide the pressure and 
temperature references.  Other than pressure testing, temperature testing was conducted 
by observing the device immersed in a temperature-controlled water environment (as 
shown in Figure 4-16) to ensure uniform temperature distribution of the parylene spiral 
tube with 0.1°C tuning resolution, using a combination of a programmable heat control 
stage as a heat generation source and a thermal couple as a temperature measurement unit.  
Experimental data (as shown in Figure 4-17) indicate linear responses of tube rotation in 
both pressure and temperature testing.  A 1.92°/mmHg pressure sensitivity and a 
6.28°/°C temperature sensitivity were obtained in a good agreement with each other 
through conversion using the ideal gas relation, which confirms the fact that 
outside pressure > inside pressure 
temperature inside the tube ?
outside pressure < inside pressure 
temperature inside the tube ?
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environmental temperature fluctuation influences tube deformation by essentially 
creating intrinsic pressure difference inside the tube.  This characterization result must be 
incorporated in future sensor design for consistent pressure-sensing accuracy under 
controlled temperature influence.  In fact, the following two methods can be used to 
reduce the effect of temperature variation in the intraocular environment: 1) seal the 
parylene tube at low pressure or even in vacuum (as in absolute pressure sensors) to 
weaken the pressure-temperature coupling; and 2) implement a sensor-pair configuration 
with different pressure reference as shown in Figure 4-18 for temperature compensation 
in the readouts [8].  Because pressure and temperature readouts can be decoupled and 
respectively obtained in the sensor-pair configuration, such a micromechanical sensor 
paradigm also has the potential for both continuous pressure and temperature monitoring 
in various systems, especially with long-term environmental monitoring needs. 
(a)         (b) 
Figure 4-15: Parylene spiral tube for temperature effect characterization. (a) Stereoscope 
image of the free-standing tube (top view). (b) SEM image of the high-aspect-ratio 
parylene channel before final release (cross-sectional view). The parylene layer was 
improperly delaminated due to chip cleavage. 
200 ?m 20 ?m
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Figure 4-16: Schematic of on-bench temperature testing setup 
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Figure 4-17: Characterization results. (a) Pressure testing. (b) Temperature testing.  
Linear measurement data indicate linearly continuous pressure and temperature responses 
of the spiral-tube sensor. 
Figure 4-18: Concept of sensor-pair configuration. Illustration adapted from [8]. 
Sensor-pair configuration: 
Feasible for both pressure and temperature measurements 
Encapsulated pressure A Encapsulated pressure B 
Different sealed pressure on each sensor 
? Same pressure but different temperature responses 
? Decoupled pressure/temperature sensing after calculation 
Device Observation
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4.5 Summary 
An implantable unpowered micromechanical parylene-based pressure sensor has 
been successfully developed in this chapter as part of a new implant paradigm using 
optical sensing methodology to realize continuous IOP monitoring.  Various geometric 
layouts for micromachined high-aspect-ratio flexible thin-walled tubes including a spiral-
tube and a long-armed-tube design have been implemented to realize pressure sensing 
with different deformation trajectories.  Depending on the target application, these 
devices are designed in a relatively large form factor to achieve high-sensitivity pressure 
responses, and in a small form factor to enable minimally invasive implantation through a 
needle.  Monolithic fabrication and packaging of the microdevices have been successfully 
demonstrated.  The micromachined IOP sensors were characterized in vitro and ex vivo,
as well as in vivo.  Testing results have yielded positive results toward practical IOP 
readouts at the mmHg level along with suture-less device anchoring after needle-based 
implantation.  Long-term performance of the parylene spiral-tube pressure sensors will 
need to be characterized to verify the stability of their behavior in the intraocular 
environment.  Such proposed optical IOP sensing method is more straightforward and 
economical than the proposed electrical sensing method as described in Chapter 3, and 
thus be a valuable focus for more studies in the future. With appropriate optical reader 
implementation, this paradigm has the great potential of fulfilling continuous, unpowered, 
real-time, reliable, and convenient IOP monitoring in glaucoma patients. 
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CHAPTER 5
IMPLANTABLE PARYLENE-BASED 
INTRAOCULAR PRESSURE 
DRAINAGE DEVICES 
5.1 Overview 
This chapter presents an implantable, unpowered, parylene-based MEMS flow 
control device for continuous and controllable intraocular fluid drainage and IOP 
regulation in glaucoma implant therapy as supplementary material to the sensors work in 
this thesis.  The device is designed to be implanted at the subjunctiva of the eye to 
provide a biomimetic drainage path similar to the natural path or the ones created by the 
state-of-the-art glaucoma drainage devices (GDDs).  It is in a tube shunt conformation so 
that a minimally invasive needle-based implantation scheme can be implemented for 
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reduced time and effort in surgical procedures.  Flexible tissue anchors are integrated into 
the implant to realize suture-less implant anchoring.  Successful in vitro and in vivo
characterizations demonstrate the functionality of the tissue anchors, alongside a 6-month 
animal study verifying the bioefficacy and biostability of such a device implant in the 
intraocular environment with no surgical or post-operative complications.  In addition, 
parylene microfluidic technology is applied to create micromachined valves with high 
mechanical and surgical/biological compliance in order to accomplish customized 
microflow regulation in an exclusive pressure-bandpass profile.  The microvalves are 
designed with appropriate dimensions for integration into a device implant in a form 
factor suitable for suture-less implantation.  Valve prototypes are developed in-channel 
(i.e., inside representative microchannel conduits) achieving 0–100 mmHg and 0–10 
?L/min pressure and flow rate regulation ranges, suitable for practical IOP drainage.  By 
incorporating these surgical and engineering features described in the following sections, 
such an implant paradigm has the great potential of fulfilling a continuous, convenient, 
and direct IOP regulation as a new alternative in glaucoma treatment. 
5.2 Surgical Design of Implant: Tissue Anchors 
5.2.1    Background 
 The implantation scheme is considered one of the most crucial factors for the 
successful implementation of bioimplants, especially when targeting delicate organs such 
as the human eye.  For example, surgical and post-operative complications of all current 
glaucoma drainage devices (GDDs) leading to device failure and even tissue deterioration 
have been discussed in the literature [1–3].  The creation of invasive large-area incisions 
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(e.g., a scleral flap) and the use of sutures may induce such deleterious consequences as 
well as increase implantation complexity.  As a result, a needle-based implantation 
scheme (as shown in Figure 5-1) is proposed in this work in order to mitigate such 
problems and further achieve minimally invasive implantation [4].  Conceptually this 
scheme is utilized for transscleral and transendothelial implants in which integrated 
flexible tissue anchors are an excellent alternative to sutures for final device fixation.  
Suture-less implant placement at subconjunctiva can therefore be accomplished. 
(a)            (b)        (c) 
Figure 5-1: Concept of the needle-based device implantation scheme. (a) Device loading 
inside a hypodermic needle. (b) Needle incision/injection at the target. (c) Device 
unloading and anchoring after needle retraction. The red region represents the implant 
location in each step with a hollow ball model used for demonstration purposes. 
5.2.2    Design and fabrication 
Figure 5-2 illustrates the design of tissue anchoring structures in foldable-arm- 
and rollable-wing-shaped conformations.  The foldable anchors consist of parylene or 
parylene/silicon arms and parylene flexural joints connected to the implant main body, 
while the rollable wings are realized using a patterned parylene slab.  The designed 
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flexible anchors can be compliantly folded or rolled so that the implants can be loaded 
into a hypodermic needle without any damage.  After needle incision and device 
unloading across the target tissue, the anchors spontaneously stretch back to their original 
conformation, enabling the implant to be fastened to the tissue after needle retraction.  
Parylene C was selected as the thin-film structural material of the designed tissue anchors 
to obtain sufficient mechanical flexibility as well as biocompatibility. 
Figure 5-2: Designs of flexible tissue anchor of the implant 
The fabrication process of the tube-type implant integrated with tissue anchors (as 
shown in Figure 5-3) is partly adapted from a modified embedded channel process [5]. 
Essential process steps include creating high-aspect-ratio parylene-refilled deep trenches 
facilitated by silicon DRIE to define foldable arms and guard columns for silicon etching, 
and forming square-like channels with large cross section using isotropic XeF2 silicon 
etching and parylene deposition/patterning. Figure 5-4 shows the microfabricated 
implants embodying approximately 150-?m-wide, 150-?m-high, 4-mm-long artificial 
microchannel conduits and flexible arm/wing parylene anchors on the ends. The 
wingspan of the stretched anchors was 800 ?m, which is larger than the needle outer 
diameter and the corresponding incision hole. 
Folded width < needle ID 
Stretched width > needle OD
Rolled width < needle ID 
Stretched width > needle OD 
Arm-shaped foldable anchor Wing-shaped rollable anchor
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Figure 5-3: Fabrication process flow of tube-type implant prototype with silicon-
embedded arms as example of anchoring structures 
Figure 5-4: Microfabricated parylene-based implants (middle) with SEM images 
highlighting their artificial conduit before release (left) and flexible tissue anchors after 
release (right). The foldable arm-shaped anchor is shown top-side up and the rollable 
wing-shaped anchor is shown bottom-side up. 
1 mm 
1 mm 
50 ?m
100 ?m
100 ?m
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5.2.3    Characterization results and discussions 
The fabricated devices were first tested in vitro to verify their functionality.  
Testing result of pressure/flow rate characterization using water as the testing fluid is 
shown in Figure 5-5, indicating that the microchannel had a fluidic conductance in the 
range of 1–10 ?L/min-mmHg, comparable to the contemporary GDDs [6].  Afterwards, 
anchor testing was conducted with the use of a customized implanter and a 22-gauge 
clinical-standard hypodermic needle.  As shown previously in Figure 5-1, the “inside-
out” implantation scheme was utilized to implant the devices through an incision created 
at the other side from the target site of the eye.  In vitro study (as shown in Figure 5-6) 
demonstrates that all devices were successfully fastened in their predetermined positions 
across the simulated eye model after needle injection, with the arm anchors providing 
better visualization due to the embedded silicon while the wing anchors were structurally 
more robust.  In vivo animal study using three live rabbit eyes as the model was also 
performed to evaluate the bioefficacy of the flexible tissue anchors in wing-shaped design 
as example.  Remarkably, the implantation surgery as shown in Figure 5-7 was able to be 
completed within 5 min due to its suture-less minimally invasive nature, implying 
minimal surgical complications could be induced.  Observation shows that the wing 
structure was stretched back after unloading from the needle, as expected.  Long-term 
follow-up study with result photographs (as shown in Figure 5-8) confirms that no device 
dislocation or post-operative complications—including inflammatory response or tissue 
encapsulation/fibrosis—were found throughout the 6-month study.  These results 
substantially verified the surgical/biological feasibility of using such an implant paradigm 
in the intraocular environment. 
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Figure 5-5: Pressure/flow rate testing result of the microchannel conduit 
Figure 5-6: In vitro tissue anchor testing. (a) Foldable arm-shaped anchor. (b) Rollable 
wing-shaped anchor 
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(a)                      (b) 
Figure 5-7: Needle-based implantation surgery of the device. (a) 22-gauge needle incision 
to inject the implant into the live eye model. (b) Suture-less anchored implant in the 
intraocular environment after surgery 
(a)                      (b) 
Figure 5-8: In vivo animal study of the flexible tissue anchor. (a) Fluorescein angiogram 
showing no noticeable blood vessel leakage at the implantation site 3 days after surgery. 
(b) Fundus photograph showing no device dislocation or post-operative complications 6 
months after surgery. The arrows indicate the implant as seen through the cornea. 
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5.3 Engineering Design of Implant: Microvalves 
5.3.1    Background 
 In addition to the aforementioned surgical features, the implant has to incorporate 
microflow control components inside the microchannel conduit for controllable flow 
regulation.  Here the microfluidic approach is implemented to fulfill the concept by 
exploiting microvalves as the key control component.  They enable systematic flow 
control for accurate and reliable operation, as well as high-level integration with other 
microfluidic components stemming from the fact that their mechanical structures are 
relatively simple [7].  Technically, microvalves are either active or passive, with passive 
valves (i.e., check valves) having the advantages of simple operation, zero power 
consumption, and ease of integration.  Because check valves can shunt fluids with a 
single pressurized flow direction they are recognized as “fluidic diodes.”  Figure 5-9 
shows the shunting behaviors of a check valve [8] and an electronic diode for comparison.  
Based on their actuation mechanism, micromachined check valves are categorized as 
normally-open valves where the fluidic channel is always open unless there is sufficient 
backward pressure [8], or normally-closed valves where the fluidic channel is blocked 
until the pressure is above cracking/threshold pressure [8, 9].  However, as indicated in 
Figure 5-9, neither type of check valve is ideal.  For normally-open (NO) valves, the 
cracking pressure to conduct forward flow is minimal, while there is always a leakage 
problem when backflow is applied.  For normally-closed (NC) valves, the backflow 
leakage can be reduced, but the cracking pressure turns out to be so large that a 
reasonable flow rate is not achievable with low pressure loading.  Given this fundamental 
knowledge, new microvalves can be developed as part of the proposed MEMS-based 
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implant paradigm achieving the required engineering and biological/medical 
specifications as stated in Chapter 2. 
(a)                        (b) 
Figure 5-9: Fluidic and electronic diodes. (a) Pressure/flow rate curve of a mechanical 
check valve. (b) I-V curve of an electronic diode for comparison 
5.3.2    Design and fabrication 
Although conventional micro check valves are not ideal in certain applications, 
different design combinations and variations can be implemented to modify the fluidic 
behaviors from those in a single valve.  Under this concept, microfluidic devices in a 
dual-valve configuration and a single-valve configuration have been separately developed 
in this work to achieve passive microflow regulation for the proposed operation.  With 
their design concept illustrated in Figures 5-10 and 5-11, both of the configurations can 
inherently regulate pressure and flow rate of fluids without any power consumption and 
greatly reduce the complexity of device fabrication and integration compared with other 
existing micro flow regulators.  A multi-layer parylene surface-micromachining 
technology with process flows illustrated in Figures 5-12 and 5-13 is utilized to fabricate 
the microfluidic devices (as shown in Figures 5-14 and 5-15) being tested in this work.  
Several important device dimensions are listed in Table 5-1; these are designed to realize 
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flow controls in a minute pressure/flow rate range as well as to achieve suitable form 
factor for needle-based minimally invasive implantation.  This specific flow regulation in 
a pressure-bandpass profile meets the operation specifications of continuous IOP 
regulation.  Details on device design and fabrication can be found in [10] and [11]. 
Figure 5-10: Concept of dual-valve configuration featuring combination of tethered-disk 
microvalves in normally-closed and normally-open check valve designs. (a) Fluidic 
behavior of normally-closed valve. (b) Fluidic behavior of normally-open valve. (c) 
Generated fluidic behavior by the dual valves in back-to-back operation. The arrows in 
valve illustrations indicate the forward flow direction. 
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(a)
(b)
Figure 5-11: Concept of single-valve configuration featuring floating-disk microvalve in 
pressure-bandpass check valve design. (a) Conceptual schematic (cross-sectional 
exploded view; not to scale). (b) Self-regulation mechanism. The arrows indicate flow 
directions through the valve.  Note the relative position between disk diaphragm and 
radiating trench channels of two-level valve seat corresponding to device operation steps. 
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Figure 5-12: Fabrication process flow of dual parylene-based microvalves 
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Silicon SiO2 ParylenePhotoresist
Thermal oxidation
Backside oxide patterning
DRIE silicon etching (back: fluidic port; front: valve seat)
1st sacrificial photoresist coating and patterning
1st parylene deposition and patterning (1 μm)
2nd sacrificial photoresist coating and patterning
XeF2 silicon roughening
2nd parylene deposition and patterning (5 μm)
3rd sacrificial photoresist coating and patterning
3rd parylene deposition and patterning (10 μm)
Silicon membrane etching
Photoresist stripping
Figure 5-13: Fabrication process flow of single parylene-based microvalve 
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Figure 5-14: Micrographs of the fabricated dual-valved channel (2 mm long in port-to-
port distance) and cut-in views of the normally-closed (left) and normally-open (right) 
parylene check valves, all in top view. The diaphragm tethers can be designed as straight 
arms or twisted arms depending on performance requirements. 
Figure 5-15: Micrographs of the fabricated floating-disk parylene single valves with 
different design variations immersed in water (top view) 
50 ?m 50 ?m
50 ?m 50 ?m
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Table 5-1: Design metrics of the in-channel microvalves developed in this work 
Dual-valve
configuration
Single-valve
configuration
Valve disk diameter 200 ?m 250 ?m
Valve disk thickness 1.5 ?m 1 ?m
Valve seat orifice diameter 100 ?m 100 ?m
Total valve width 460 ?m 400 ?m
Channel width 400 ?m* 350 ?m* 
Channel height 20 ?m 20 ?m
Channel length 2,000 ?m 1,800 ?m
Channel thickness 10 ?m 10 ?m
*500 ?m at the valved sections 
5.3.3    Characterization results and discussions
 Microfabricated in-channel parylene microvalves were tested using the fluidic 
setup illustrated in Figure 5-16.  A customized testing jig featuring PEEK (poly-ether-
ether-ketone) material was used to provide a macroscale/microscale fluidic interface with 
diced chips, so that microflows could be introduced with regular Teflon capillary tubing 
to the devices through their backside fluidic access ports [12, 13].  The jig was immersed 
in water when packaging the floating-disk valves in order to avoid stiction occurrence at 
an air-liquid-solid interface on the microvalves.  Air bubbles in the entire fluidic path 
need to be completely removed prior to valve characterization to ensure reliable 
microvalve operation.  For demonstration purposes, clean water served as the fluid source 
for device characterization.  On the front end of the jig, an off-chip pressure regulator and 
a pressure gauge were connected to control the injection pressure of the fluids with 0.07 
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kPa (~ 0.01 psi, ~ 0.5 mmHg) tuning resolution.  Pressure readouts were recorded in 
gauge pressure format to indicate the additional pressure loading from the injected fluids 
relative to atmospheric pressure.  Hydrostatic pressure differences due to any height 
difference of the column in the testing system were carefully calibrated for accurate 
pressure control.  Flow rate measurement and fluid collection was performed on the back 
end of the jig.  Water flow rate was measured by recording its marching velocity in the 
capillary enabled by its relatively small flow rates (?L/min range).  In marching velocity 
recording, given the fact that the resolution was limited to 0.5 mm in marching distance 
and 1 s in marching time in the testing setup, the overall flow rate measurement error was 
typically 5%–15%, depending on the flow rate level.  Using these measurement 
techniques with the stated considerations, pressure/flow rate behavior of the in-channel 
microvalves could be well characterized. 
Pressure
Regulator
Fluid Source
Pressure
Gauge
Flow Marching Velocity 
Measurement
Customized 
Testing Jig
(immersed in water)
Fluid Collection
Figure 5-16: Schematic of fluidic testing setup for device characterization. The jig was 
immersed in water if packaging single floating-disk valves to avoid stiction effect. 
Representative pressure/flow rate testing results of the micromachined in-channel 
valves in both dual-valved and single-valved configurations were shown in Figures 5-17 
and 5-18, with reliable and repeatable behaviors from the same device in cyclic operation 
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regardless of errors in gauge pressure and marching velocity/flow rate measurements.  
They successfully demonstrated passively controlled microflow in 0–100 mmHg and 0–
10 μL/min bandpass regulation ranges under the fabricated device dimensions.  Both 
low-off and high-off flow shunting characteristics were achieved in experiments given 
the result of no observable water flow below the threshold pressure point and greatly 
reduced flow rate beyond the cut-off pressure point.  The threshold and cut-off pressures 
were characterized to be approximately 10 mmHg and 50 mmHg in the dual-valved 
device and 10–20 mmHg and 65–75 mmHg in the single-valved device.  Higher 
variations of the pressure characteristics in the single floating-disk microvalve were 
caused by imperfect valve disk-seat-cap alignment due to: 1) uncontrollable in-plane disk 
movement during operation; and 2) double-side pattern misalignment on the wafer.  
These two misalignments can change the boundary conditions of the bendable disk 
including the effective overhang and the pressurized area of the disk diaphragm.  All 
these factors can accordingly vary the device performance as the experimental results had 
approximately 30%–50% discrepancy from the designed threshold and cut-off pressures, 
so that further study and analysis will need to be conducted to address this issue.  
Moreover, the following three factors related to the fabrication process contributed to the 
resultant performance variation in both valved configurations: 1) thickness control of 
photoresist coating; 2) thickness control of parylene deposition; and 3) material property 
control of thin-film parylene.  Consequently, more process calibration and 
characterization should be conducted in order to enhance uniformity of the device 
performance so that the bandpass pressure regulation range can be precisely controlled 
depending on specific applications.  The maximum water flow rate of the devices in dual-
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valved configuration was lower than that in single-valved configuration (1.3 ?L/min and 
7.9 ?L/min, respectively) because of the difference in fluidic resistance.  Nevertheless, 
the overall fluidic resistance could be modified by having different dimensions of the 
microvalve and/or the encapsulating microchannel, so as to appropriately meet the design 
specification of practical IOP drainage.  Under backward flow injection, the devices in 
both configurations were able to withstand high pressure as they remained leakage-proof 
when operated under pressure loadings greater than 1,000 mmHg.  These characterization 
results demonstrated that such valved microfluidic devices achieved pressure-bandpass 
flow control suitable for physical intraocular fluid drainage and IOP regulation.  More 
device testing results of the individual valves (i.e., normally-closed tethered-disk valve, 
normally-open tethered-disk valve, and floating-disk valve) developed in this work are 
listed in Table 5-2, with details in [10] and [11] for basic reference of valve 
implementation in practical implant systems. 
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Figure 5-18: Single valve characterization result to water microflow control 
Table 5-2: Comparison of the developed parylene-based microvalves 
in regular check valve operation for flow shunting 
Normally-closed 
valve
Normally-open 
valve
Floating-disk
valve
Valve disk design Tethered disk Tethered disk Floating disk 
Occupied area* 10-7 m2 10-7 m2 10-7 m2
Valve void volume ~ 3 nL ~ 1 nL ~ 1 nL 
Cracking pressure ~ 10 mmHg < 5 mmHg ~ 0 
Reverse-leakage
stop pressure ~ 0 > 50 mmHg ~ 0 
Breakdown pressure > 1,000 mmHg > 1,000 mmHg > 1,000 mmHg 
*?Calculated order of scale 
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Two different microvalved design configurations (dual-valved and single-valved) 
for flow controls have been reported as adequate candidates to be included in the IOP 
drainage device implant, but each of them has its own advantages and disadvantages.  
These considerations in their use of pressure-bandpass flow controls are compared in 
Table 5-3.  With these engineering findings, current work is underway to incorporate 
such parylene-based microvalves in tube shunt implants for in vivo studies of controllable 
continuous intraocular fluid drainage and associated IOP regulation in practice.  For 
example, a proof-of-concept experiment has been conducted featuring a dual-valve-
packaged implant shown in Figure 5-19 as the initiative [14].  These studies 
experimentally verify the feasibility and possibility of integrating all of the surgical and 
engineering device features in the ultimate MEMS-based implant in the future. 
Table 5-3: Comparison of the developed parylene-based microvalves 
with implementation considerations 
Dual-valved 
configuration
Single-valved
configuration
Valve disk design Tethered disk Floating disk 
Number of valves required to 
accomplish the flow control profile 2 1 
Design constraints high low 
Fabrication complexity high moderate 
Handling after fabrication easy difficult 
Device reliability moderate high 
Pressure characteristics variation low high 
Surgical/biological compliance high high 
 130  
Coupling tube
100 μm 200 μm
Fluid
direction
100 μm
Fluid
direction
NO valveNC valve
(a)
(b)
Figure 5-19: Concept of representative dual-valved tube shunt implant integration for in 
vivo study [14]. (a) Post-fabrication assembly illustration. (b) Stereoscope image of 
assembled tube shunt device prototype. Images courtesy of Mr. Jeffrey C. Lin. 
100 ?m
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5.4 Summary 
 An implantable unpowered micromechanical parylene-based microfluidic device 
has been proposed in this chapter as part of a new implant paradigm to realize continuous 
and controllable physical IOP drainage.  Surgical and engineering features are separately 
presented with complete design, fabrication, and characterization description in order to 
demonstrate the concept of such an implant.  On the surgical side, the implant is designed 
to be a tube shunt type, with integrated flexible tissue anchors facilitating a minimally 
invasive suture-less needle-based device implantation scheme at the subconjunctiva of 
the eye, in order to provide a biomimetic intraocular fluid drainage path.  Long-term in
vivo animal study has verified the feasibility of the biocompatible implant prototype 
placed in the intraocular environment.  On the engineering side, two device prototypes, in 
dual-valved and single-valved design configurations, have been developed to accomplish 
the flow control function of the implant, with the demonstrated performance suitable for 
physical intraocular fluid drainage and IOP regulation.  These experimental studies 
preliminarily verify feasibility of such device features for use in the ultimate MEMS-
based implant.  With future development on the integration of these features, such a 
device implant can be realized as a prospective means to fulfilling continuous, convenient, 
and direct IOP regulation for practical glaucoma treatment. 
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CHAPTER 6
CONCLUSIONS
Over the years, researchers and engineers have proved MEMS to be an enabling 
technology for numerous applications covering physical, chemical, and biological 
domains in defense and commercial markets.  The access of MEMS to interaction with 
the microscopic world through those tiny little micromechanical structures facilitates 
smaller, cheaper, and faster solutions to target sensing, actuating, and control compared 
with conventional mechanical/electrical components.  Integration of such microdevices, 
possibly with microelectronics, realizes high-level system applications.  After successful 
demonstration of physical MEMS, optical MEMS, and RF MEMS—given their stable 
growth in industry nowadays—the next territory to be expanded on the microtechnology 
portfolio is microfluidics, bioMEMS, and medical MEMS for life science and health care, 
driven by the increasing need for better quality of life. 
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Backed by profound study of parylene as a biocompatible MEMS material in our 
research group, this thesis investigates the possibility of this parylene MEMS technology 
in development of implantable medical microdevices.  As a continuation with the 
reported applications in cortex neural probes, spinal cord electrode arrays, and retinal 
prosthesis, two kinds of intraocular MEMS implants involving pressure sensors and 
valved flow-control devices have been developed in this work for medical application in 
glaucoma study and management.  Clinical findings of the correlation between 
neuropathy and a physiological parameter (i.e., intraocular pressure (IOP)) in glaucoma 
provide a basis for the proposed approaches that utilize MEMS implants to physically 
monitor and regulate the IOP in glaucoma patients.  With a great emphasis on pressure 
sensors, followed by supplemental description of pressure regulation devices, the 
complete design, fabrication, characterization, and analysis of such microdevices have 
been presented in this thesis, thus demonstrating their feasibility and potential for 
meeting the engineering and surgical/biological specifications of the proposed 
applications.  More importantly, studies with the use of these MEMS implants have 
demonstrated applicable minimally invasive implantation schemes, as well as device 
chronic biocompatibility in the intraocular environment (given the evidence of 
no/minimal observed surgical or post-operative complications).  These parylene-based 
MEMS implant paradigms have performed significant and promising results not achieved 
by previous MEMS or non-MEMS devices/implants due to technology barriers either in 
manufacturing or material aspect. 
Certainly there were lots of trials and iterations conducted before successful 
demonstration of the devices presented throughout this thesis.  This fact may be more 
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obvious as compared with other types of MEMS devices because more concerns and 
unknowns exist in such interdisciplinary fields as that of emerging engineering and 
biology/physiology/medicine.  Through this work, we understand that device 
biocompatibility is extremely important for in vivo applications, and thus any planning of 
design, fabrication, and packaging of the device should be thoroughly examined to 
address possible surgical and biological issues from the beginning of process, in order to 
effectively reduce associated time and effort in the entire development cycle.  In addition, 
this work mainly focuses on device development, while more studies on device-to-world 
interfacing will be required from the system-level view for ultimate use in practice, 
especially in the implementation of the external reader in the IOP sensor example.  We 
can foresee that most cost and challenges would fall upon the reader part in the overall 
monitoring system, as has already been shown in other developed wireless 
sensing/detection paradigms, such as radio-frequency identification (RFID). 
Initiated with ophthalmic applications as the first demonstration, the developed 
biocompatible parylene-based MEMS implants are completely adaptable to other 
biomedical applications as long as the corresponding physiological parameters can be 
monitored/regulated by the physical operating principles in the device nature.  
Representative examples include, but are not limited to, cardiovascular pressure 
monitoring, intracranial pressure monitoring, cerebrospinal fluid (CSF) drainage, blood 
flow regulation, hypertension control, and other detections and controls involved during 
neurosurgeries.  It can be anticipated that such parylene MEMS technology will evolve 
into more interesting and useful device derivatives in the future. 
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APPENDIX
INTRODUCTION TO MEMS 
TECHNOLOGY
A.1 MEMS 
A.1.1    Origin and definition 
There is no doubt that our science voyage to “Lilliput”—the microscopic world—
was initiated by two remarkable talks: “There’s Plenty of Room at Bottom [1],” and 
“Infinitesimal Machinery [2],” delivered by the contemporarily prestigious physicist 
Richard P. Feynman.  Even though he himself could not see the real use of these 
micromachines at that time of his presentations, he successfully anticipated the future 
research trend toward exploring a brand new field: microtechnology or nanotechnology.  
As shown in Figure A-1 [3], those microdevices (including “micromachinery” as 
Feynman called them) have characteristic lengths in the range of 1–100 ?m, smaller than 
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the diameter of human hair and comparable to that of bacteria and human cells.  Because 
of this, numerous promising applications can be derived that benefit by their size and 
associated scaling laws [4]. 
Figure A-1: Scale of things. 1 m = 106 ?m = 109 nm = 1010 Å. Image reprinted from [3]. 
With almost 50 years of research and development by scientists and engineers, 
microtechnology has become a practical and viable solution to many scientific and 
engineering problems/challenges nowadays [4–9].  It enables us to explore new 
phenomena at the microscale for extensive applications.  The associated implementation 
platforms are usually recognized as micro-electro-mechanical systems (MEMS) or 
microsystems, which embody micromechanical structures and microelectronics as core 
components to accomplish sensing, actuating, and computing functions (as shown in 
Figure A-2).  Micromechanical structures are intensively emphasized in MEMS as they 
are the key to realization of the transducing/interfacing concept.  They crucially create the 
communication interface between the macroworld (“Brobdingnag,” i.e., humans/users) 
and the microworld (“Lilliput,” i.e., targets at the microscale) in interdisciplinary 
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operations covering physical, chemical, electrical, mechanical, optical, and biological 
domains.  MEMS can also provide smaller, faster, cheaper, and more effective solutions 
as compared with conventional bench-top approaches in many circumstances, all because 
of the nature of miniaturization. 
Figure A-2: MEMS implementation concept with micromechanical structures as the key 
to realization of macro-to-micro communication and interfacing. Image adapted from [4]. 
A.1.2    Technology 
MEMS are highly correlated with semiconductor integrated circuits (IC) because 
their microfabrication processes are identically based on silicon processing technology.  
Accordingly, their fabrication facilities are ideally interchangeable based on batch-
fabrication [10] and pattern transfer [9, 11] concepts as shown in Figures A-3 and A-4, 
respectively.  Instead of creating electronic components and circuitry, MEMS technology 
mainly focuses on development of micromechanical structures and devices dealing more 
with mechanical, thermal, and other properties.  Because of their similarities on the 
fabrication side, the rapid growth of the IC industry, with revolutionary progresses in 
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microelectronics [12] (as shown in Figure A-5) has resulted in the growth of the MEMS 
industry as well, with several representative examples [13–15] (as shown in Figure A-6) 
indicating the enhancement of both design and fabrication complexity by the recent 
technology push.  As more evidence of continuous MEMS technology development, the 
recent growth in MEMS integration given in Figure A-7 shows a trend similar to the 
well-known “Moore’s law” [16] in terms of device density. 
Figure A-3: Concept of batch-fabrication 
process in silicon processing technology. 
Close-ups are shown in the sequence of (a)–(d). 
Image reprinted from [10]. 
Figure A-4: Concept of pattern-transfer process in silicon processing technology. (a) 
Process flow. (b) Involved process steps. Images reprinted from [9] and [11]. 
(b)(a)
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(a)            (b)              (c) 
Figure A-5: Microelectronics development. (a) The first transistor from Bell Labs 
(Murray Hill, NJ) in 1947. (b) The first IC from Texas Instruments (Dallas, TX) in 1958. 
(c) Pentium® 4 chip from Intel (Santa Clara, CA). Images adapted from [12]. 
(a)                         (b)              (c) 
Figure A-6: MEMS development. (a) The first resonant gate transistor [13] from 
Westinghouse (Monroeville, PA) in 1967. (b) The first micromotor [14, 15] (next to a 
human hair) from the University of California at Berkeley in 1989. (c) DLP® chip (next 
to a household pin) from Texas Instrument (Dallas, TX) 
Figure A-7: Comparable trend of MEMS 
technology development to Moore’s law 
in IC industry. Image reprinted from [16]. 
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Because of different focus, as stated previously, MEMS fabrication technology 
over the years has evolved to be “micromachining” to differentiate itself from IC-type 
microfabrication.  Other than standard silicon processing techniques [17] including 
photolithography, oxidation, doping, thin-film deposition, wet chemical etching, and dry 
plasma etching, special techniques [6]—such as HNA/KOH/TMAH (wet) and XeF2 (dry) 
silicon etching, electroplating, LIGA (German acronym for x-ray lithography, 
electroforming, and molding), deep-reactive-ion etching (DRIE), and wafer bonding—
have also been developed in silicon-based micromachining to enable fabrication of 
complex 2-D and 3-D mechanical structures out of silicon wafer (as shown in Figure A-8 
[12]).  They are generally categorized as bulk micromachining and surface 
micromachining and are respectively described as follows. 
Figure A-8: Silicon-based micromachining technology including bulk micromachining 
(left) and surface micromachining (right).  Image reprinted from [12]. 
Bulk micromachining [18] refers to selectively removing/etching significant 
amounts of substrate material—silicon in most cases—to create the designed structures.  
By using different kinds of etching methods, the silicon substrate can be orientionally 
(isotropically or anisotropically) micromachined (as shown in Figure A-9) so as to create 
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a wide variety of micromechanical structures [19] for different purposes.  Since the 
invention of DRIE process [18], the capability of bulk micromachining has been 
expanded to create vertical holes/trenches so that high-aspect-ratio (HAR) structures (as 
shown in Figure A-10) can be realized for more extensive applications. 
Figure A-9: Bulk-micromachined structure examples.  Image reprinted from [19]. 
(a)                                 (b) 
Figure A-10: Examples of high-aspect-ratio (HAR) structures created by DRIE. (a) Leaf  
spring. (b) Comb beams. Image reprinted from [18]. 
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Surface micromachining [20] refers to sequentially depositing and patterning 
layers of thin-film sacrificial and structural materials on the surface of the substrate to 
create the designed structures after releasing the sacrificial material (as shown in Figure 
A-11).  Given this concept and the available delicate patterns on the photomasks, highly 
complex surface-micromachined devices can be built as shown in Figure A-12.  Not only 
planar structures, but out-of-plane structures/devices (as shown in Figures A-13 and A-14) 
can also be realized using surface micromachining with the assistance of sophisticated 
manipulation and/or assembly techniques [21] after fabrication. 
Figure A-11: Concept of surface micromachining. Image courtesy of Southwest Research 
Institute (SwRI). 
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(a)                            (b) 
Figure A-12: Micromachined structures by SUMMiT™ Technologies. (a) Multiple gear 
speed reduction unit. (b) Gear alignment clip. Images courtesy of Sandia National 
Laboratories.
Figure A-13: Micro optics system including laser, 3 Fresnel lenses, beam splitter, and 45° 
mirror. Images courtesy of Dr. Ming C. Wu. 
(a)                              (b) 
Figure A-14: Assembled 3-D microstructures. (a) Pop-up box. (b) Model of UC Berkeley 
Campanile clock tower. Images reprinted from [21]. 
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Because of the maturity of both processing techniques, state-of-the-art 
micromachining often involves hybrid processes in which both bulk and surface 
micromachining are applied to realize specific structures and enhance their performance.  
Critical issues/challenges such as CMOS/MEMS integration, system integration, 
packaging, and reliability are mainstream in current research topics of fabrication 
technologies toward the successful development and commercialization of MEMS. 
A.1.3    Products and market 
 With successful technology development, versatile MEMS products have been 
brought to the market from both academic and industrial efforts.  This evolution can be 
clearly seen from Figure A-15 [22].  Nowadays MEMS business is still in rapid growth, 
with estimated global market reaching 10.8 M USD in 2011, as shown in Figure A-16 [23] 
(even only when taking into account silicon/quartz-based devices).  As of 2008, more 
than 450 MEMS industrial players worldwide have been identified, with geographical 
breakdown shown in Figure A-17 [24]; the top 30 players are listed in Figure A-18 [25]. 
Figure A-15: MEMS evolution. Images reprinted from [22]. 
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Figure A-16: Analysis of global MEMS market 2006–2011. Images reprinted from [23]. 
Figure A-17: Geographical breakdown of MEMS players. Image adapted from [24]. 
Figure A-18: Top 30 worldwide MEMS manufacturers (ranked by estimated 2007 
revenues). Image reprinted from [25]. 
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Given the demonstrated progress on physical, optical, and RF MEMS products, 
the next wave is unanimously believed to be on bioMEMS, lab-on-a-chip systems, 
implantable MEMS devices/systems, or generic MEMS components for life sciences.  
The expected business growth is shown in Figure A-19, implicitly reflecting the high 
need of such products in the market. 
Figure A-19: Analysis of MEMS components for life sciences market 2005–2012. Image 
reprinted from [26]. 
A.2 Implantable Medical MEMS 
 Implantable medical MEMS, or MEMS implants, are a rising field and have 
attracted significant attentions from engineering, biological, and medical societies [27–
30].  This emerging technology aims to apply microtechnologies/microdevices to human 
health care, driven by the increasing desire for better study of physiology and for better 
quality of life.  Critical building blocks of such devices/systems include processing, 
packaging, communication, power, and materials—especially the latter two.  Because the 
devices are designed to be implanted inside the human body, their power consumption 
and biocompatibility come first in minimizing interference to the body tissue and meeting 
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regulatory requirements (e.g., approval from the Food and Drug Administration (FDA) in 
the U.S.).  Inclusion of MEMS processing technology favorably facilitates fabricated 
devices in a small form factor, suitable for minimally invasive and painless implantation, 
as well as for placement inside delicate organs or at specific locations to accomplish 
specific operations.  Prospective application targets cover the human body, as shown in 
Figure A-20 [30].  Depending on their use, the state-of-the-art MEMS implants can be 
categorized into acute (temporary) and chronic (long-term) types, as shown in Figures A-
21 and A-22, respectively, with more detailed descriptions in [30]. 
Figure A-20: MEMS for implantable applications. Image reprinted from [30]. 
Nomenclature
Electrical: electrical 
stimulation and 
sensing and includes 
micro stimulators. 
Sensors:
P – Pressure 
A – Acceleration 
Fl – Flow 
AC – AC conductance 
M – Magnetic 
S – Strain 
Fo – Force 
M – Multiple 
V – Viscosity. 
Others: collection of 
other MEMS 
paradigms 
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Figure A-21: Graphical overview of acute MEMS implants. Image reprinted from [30]. 
Figure A-22: Graphical overview of chronic MEMS implants. Image reprinted from [30]. 
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From the examples in Figures A-21 and A-22, it is evident that the implantable 
medical MEMS diverge from typical MEMS paradigms based on exclusive device 
concepts and material selections.  Conventional MEMS materials, including silicon and 
CMOS-compatible thin films, are not the only choices in this field.  In fact, use of 
polymeric materials has been found to allow implants to have more flexibility, more 
processing availability, more shaping possibility (including 3-D conformations), easier 
packaging and integration, lower cost, and more configurable 
structural/chemical/biological functionalities.  Associated polymeric MEMS materials 
and polymer micromachining have therefore been broadly researched and engineered to 
pursue ultimate realization of certain ideal MEMS implants. 
A.3 Polymeric MEMS Materials 
A.3.1    Overview 
 Polymers (including elastomers, plastics, and fibers) have been increasingly 
exploited as MEMS materials since the 1990s [31], motivated by the aforementioned 
reasons.  Typical microfabricated structures include device substrates, structural thin 
films, functional thin films, adhesives, packaging, and coating, mainly for flexible 
devices and life science applications.  Table A-1 summarizes representative polymeric 
MEMS materials as well as their processing methods and demonstrated applications.  
Because of their ease of processing and configurable functionalities, polymeric materials 
are prevalent in microfluidics for flow control and fluid transportation components.  
More knowledge of polymers has been adapted to micromachining technologies in order 
to construct functional and reliable MEMS devices/systems.  Among the listed polymers, 
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parylene has exclusive physical/chemical/biological properties, so it is specifically 
discussed in the following to justify the development of parylene-based MEMS implants 
in this work. 
Table A-1: Representative polymeric MEMS materials. Table adapted from [31]. 
Material Processing methods Demonstrated applications 
Parylene
(poly-para-xylene) Chemical vapor deposition 
Microfluidics; flexible 
structures and devices 
Polyimide Spin coating; extrusion Substrates; microfluidics 
Acrylics Molding High-aspect-ratio structures; microfluidic channels 
PDMS
(poly-dimethyl-siloxane) Molding 
Microfluidic channels, pumps, 
and valves 
Liquid crystal polymer Chemical etching Flow sensors 
Biodegradable polymer Molding Drug delivery devices 
SU-8 epoxy Photo patterning; spin casting Artificial haircell sensors; microfluidic gaskets 
Poly-urethane Molding Micromechanical structures 
Nanocomposite elastomer Screen printing; molding Conductors; sensors and actuators
A.3.2    Parylene 
 Parylene (poly-para-xylene) as a MEMS material has been extensively 
investigated in our research group since the last decade [32, 33].  While its invention can 
be traced back to 1947 [34], it was commercialized in 1965 by Union Carbide 
Corporation (now Specialty Coating Systems Inc., Indianapolis, IN).  Parylene is the 
official trade name for a family of semicrystalline thermoplastic polymers.  Figure A-23 
gives currently commercially available parylene types [35], where parylene N (no 
chlorines on the benzene ring), parylene C (one chlorine on the benzene ring), and 
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parylene D (with two chlorines on the benzene ring) are the originally commercialized 
derivatives, while other types such as parylene HT (fluorinated version) and dix A/AM 
(amino function groups on the benzene ring) are also available from Specialty Coating 
Systems and Kishimoto Sangyo Co., Ltd in Japan, respectively. 
Figure A-23: Commercially available parylene types. Image reprinted from [35]. 
 The preparation of parylene is conducted by the Gorham vapor-deposition process 
[36–38], a room-temperature chemical vapor deposition (CVD) polymerization process 
as shown in Figure A-24 with parylene N as an example.  The commercially available 
dimer (di-para-xylene) in powder form is placed in the vaporizer to be sublimated at 
elevated temperature (120–150°C), then broken into monomers when it passes through 
the pyrolysis furnace at 650–750°C.  The monomers enter the deposition chamber, which 
is held at room temperature, and conformally polymerize all exposed surfaces without 
pinholes.  The process pressure is in the range of 20–35 mT to modify the monomer 
mean free path to the coated substrate.  Residual monomer is collected on the cold trap.  
Different process conditions need to be applied to perform deposition of different variants 
of parylene.  Typical deposited parylene film thickness from a single run is 0.1–30 ?m in 
a PDS 2010 Labcoater™ system from Specialty Coating Systems. 
 156  
Figure A-24: Parylene preparation. (center) Process diagram. (left) Chemical structures at 
corresponding steps. (right) Photograph of actual deposition system (PDS 2010 
Labcoater™ from Specialty Coating Systems). Images reprinted from [37, 38]. 
 The material properties of parylene summarized in Tables A-2 and A-3 [38, 39] 
indicate its potential for electrical, mechanical, and physical applications.  More 
importantly, its thin-film nature, chemical/biological inertness, and excellent barrier 
characteristics (low water absorption and low gas/liquid permeability) enable parylene to 
be used as a coating material in the electronics and medical industries, with successful 
demonstrations in pace-makers and other cardiac assist devices, stents, surgical tools, 
implantable electronics, and catheters [40, 41].  Studies have confirmed that parylene C is 
a long-term biocompatible material meeting ISO 10993 standard and United States 
Pharmacopeia (USP) Class VI grade (the highest biocompatibility rating for plastics in 
the U.S.) [39–43].  Furthermore, parylene C films have been implanted in live rabbit eyes 
for six months with no detectable adverse immune response such as inflammation, tissue 
fibrosis, or other post-operation complications [38]. This fact strongly supports the 
biocompatibility and biostability of parylene in the unique intraocular environment. 
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Table A-2: Material properties of parylene N, C, D, and HT. Table adapted from [38]. 
Property Parylene N Parylene C Parylene D Parylene HT 
Dielectric strength 
(V/mil), 1 mil film 7,000 5,600 5,500 5,400 
     
Dielectric constant 
60 Hz 
1 kHz 
1 MHz 
2.65 
2.65 
2.65 
3.15 
3.10 
2.95 
2.84 
2.82 
2.80 
2.21 
2.20 
2.17 
     
Young’s modulus (psi) 350,000 400,000 380,000 — 
     
Yield strength (psi) 6,100 8,000 9,000 — 
     
Elongation to break (%) 20–250 200 10 — 
     
Coefficient of friction 
Static
Dynamic 
0.25 
0.25 
0.29 
0.29 
0.33 
0.31 
0.145 
0.130 
     
Density (g/cm3) 1.10–1.12 1.289 1.418 — 
     
Melting point (°C) 420 290 380 > 450 
     
Thermal conductivity at 
25°C (10-4 cal/cm-s-°C) 3.0 2.0 — — 
     
Specific heat at 20°C  
(cal/g-°C) 0.20 0.17 — — 
     
Water absorption  
(% after 24 hours)  < 0.1 < 0.06 < 0.1 < 0.01 
     
Index of refraction 1.661 1.639 1.669 — 
Table A-3: Comparison of parylene N, C, and HT.  Table adapted from [38]. 
Property Parylene N Parylene C Parylene HT 
Thickness Control Excellent Excellent Excellent 
Coating Speed Medium High Low 
Crevice Penetration Better Good Best 
Hardness Better Good Best 
Coefficients of Friction Better Good Best 
Thermal Stability Moderate Moderate Excellent 
Gas Permeability Better Best Good 
Moisture Resistance Better Best Good 
Chemical Resistance Excellent Excellent Excellent 
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 Micromachining of parylene involves film deposition, photolithography (pattern 
generation), and oxygen plasma etching (pattern transfer), all of which can be done at low 
temperatures (< 120°C).  Parylene C (poly-chloro-p-xylylene) is frequently used as the 
MEMS material because of its processing convenience and satisfactory material 
properties, so the mentions of parylene in this work are assumed to refer to parylene C 
unless stated otherwise.  Although standard silicon wafers are usually used for process 
compatibility, the coated substrate can be made out of virtually any material.  The 
processed parylene film from a silicon substrate (as shown in Figure A-25 [44]) 
maintains its original flexibility and transparency.  As a result, the entire process is 
compatible with general CMOS/MEMS microfabrication processes, and thus can be 
expanded to multi-layer parylene surface micromachining technology that integrates 
silicon and metal processes (as shown in Figure A-26) to build complex parylene-based 
structures and features [45].  Device examples facilitated by such enabling technology are 
given in Figure A-27 [32, 46] with a great focus on microfluidic components such as 
fluid channels/columns, pumps, valves, filters, pressure/flow sensors, mass flow 
controllers, and electrospray nozzles.  An integrated parylene-based microsystem for 
serial on-chip liquid chromatography and tandem mass spectrometry (LC-MS/MS) is 
shown in Figure A-28 [47] as a demonstration of applying such technology. 
Figure A-25: Processed parylene film from a silicon wafer. Image reprinted from [44]. 
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Figure A-26: Concept of low-temperature multi-layer parylene micromachining 
technology. Diagram reprinted from [45]. 
Figure A-27: Microfabricated parylene-based devices. Images reprinted from [32, 46]. 
Figure A-28: Integrated parylene LC-MS/MS microsystem. Image reprinted from [47]. 
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Similar to other polymers such as polyimide, silicone, PMMA, and SU-8, trials 
using parylene in MEMS medical implants have been investigated more versatile shapes 
and functions, due to its thin-film nature, as compared with other bulky candidates.  
Depending on surgical placements and associated procedures, parylene can be used as a 
coating material on rigid structures or directly used as a structural material.  For example, 
parylene-coated silicon neural probes having multi-electrode arrays (MEAs) and 
integrated with flexible parylene cables have been reported (as shown in Figure A-29) for 
multi-channel cortex neural signal recording and stimulation [48].  On the other hand, 
flexible devices having MEA in different density and configuration have been reported 
for spinal cord and retinal stimulation as shown in Figures A-30 and A-31, respectively 
[38].  Facilitated by the use of parylene, all the demonstrated implants are identified as 
having minimally invasive features and high biocompatibility for chronic implantation.  
Given such technology, therefore, diverse parylene-based MEMS medical implant 
paradigms can be created to ultimately benefit people’s lives. 
(a)                         (b) 
Figure A-29: Neural probe implant for cortex signal recording and stimulation. (a) 
Concept and surgical placement. (b) Microfabricated parylene-coated silicon neural probe 
with flexible parylene cable for electrical interconnection. Images reprinted from [48]. 
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(a)                                 (b) 
Figure A-30: Spinal cord prosthesis for neural stimulation. (a) Concept and surgical 
placement. Animal is drawn as the illustrative model. (b) Microfabricated parylene-based 
MEAs with designed surgical features. Images reprinted from [38]. 
          
(a)                          (b) 
Figure A-31: Integrated intraocular prosthesis for retinal stimulation. (a) Concept and 
surgical placement. The parylene-based MEA is designed to be located at epiretina in the 
intraocular environment. (b) Fundus photograph of high-density (1024 pixels) parylene-
based MEAs tacked to the retina of a canine eye. Images reprinted from [38]. 
Intraocular
RF coil
Packaged
ASIC
High lead-count
flexible cable
Epiretinal
multielectrode
array
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A.4 Summary 
 This appendix gives an overview of MEMS definition, trend, and evolution.  Core 
MEMS processes, including bulk and surface micromachining, are briefly described to 
show the capability of such enabling technology in microfabricated devices/systems 
covering a wide variety of applications, including implantable MEMS (MEMS implants).  
Minimally invasive biocompatible medical microdevices can be created with suitable 
form factor and material from designed MEMS processes.  Among all available solid-
state and polymeric MEMS materials, parylene has exclusive properties, such as high 
mechanical flexibility, great chemical resistance, electrical insulation, optical 
transparency, and ease of processing.  A CMOS/MEMS-compatible multi-layer parylene 
micromachining technology has been developed to fabricate flexible and reliable 
parylene-based microdevices.  With seamless combination of design, material selection, 
and technologies, various biocompatible parylene-based MEMS implants can be realized, 
with great potential for medical applications. 
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